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Introduction:  In developing countries the prevalence of malnutrition on admission amongst 
children with cancer can be as high as 69%.  High rates of malnutrition occur due to factors such as 
poverty, co-morbidities, late presentation and advanced disease process.  Weight has been shown to 
be an inaccurate parameter for nutritional assessment of patients with solid tumours as it is 
influenced by tumour mass.  The importance of nutritional resuscitation and support of children 
with cancer has been emphasised in the literature, however, nutritional assessment and management 
of children with cancer is not consistently implemented throughout the centres treating these 
patients.  Malnutrition on admission has been shown to increase the risk of toxicity and infection 
amongst children with cancer.  The influence of malnutrition at the time of admission on outcome 
has not, however, been conclusively established. 
 
Aim:  The aims of this study were to determine the prevalence of malnutrition amongst children 
with Wilms‟ Tumour on admission to hospital, as well as the influence thereof on outcome after 
two years.  Furthermore, it aimed to determine the level of nutritional support that the children 
received on admission to hospital.  
  
Objectives:   
a) To determine the prevalence of malnutrition using a combination of anthropometric and 
biochemical markers, defined by the AHOPCA algorithm. 
b) To determine the influence of nutritional status on admission on the outcome, in terms of 
overall survival and death, amongst children with Wilms' Tumour admitted to IALCH 
between 2004 and 2012. 
c) To determine the level of nutritional support prescribed to children with Wilms‟ Tumour 
within the first two weeks of admission to IALCH between 2004 and 2012. 
 
Methods:  Seventy six children diagnosed with Wilms' Tumour and admitted to IALCH between 
2004 and 2012 were studied prospectively.  Nutritional assessment took place before starting 
treatment and included weight, height, mid upper arm circumference (MUAC), triceps skinfold 
thickness (TSFT) and serum albumin.  Overall nutritional status was classified using a combination 
of MUAC, TSFT and albumin.  Outcome was determined at two years after the date of admission.  







Results:  Stunting and wasting was evident in 12 and 15% of patients, respectively.  By classifying 
nutritional status using a combination of MUAC, TSFT and albumin, the prevalence of malnutrition 
was shown to be 67%.  Malnourished children did not have significantly larger tumours than those 
who were well-nourished on admission.  Malnutrition was not a predictor of poor outcome at two 
years after admission.  Eighty four percent of patients received nutritional resuscitation within two 
weeks of admission, in the form of oral supplements, nasogastric feeds, or a combination thereof. 
 
Conclusion:  When classifying nutritional status, utilisation of weight and height in isolation can 
lead to underestimation of the prevalence of malnutrition amongst children with Wilms' Tumour.  
Nutritional assessment and classification of children with solid tumours should include MUAC and 
TSFT.  Malnutrition at the time of admission was not shown to be related to poorer outcome after 
two years.  This may be due to the effects of early aggressive nutritional resuscitation as part of 
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CHAPTER 1: INTRODUCTION TO THE PROBLEM AND ITS SETTING 
 
1.1. Importance of the study 
Different types of childhood cancers and the prevalence thereof, vary by age (Ward, 
DeSantis, Robbins, Kohler & Jemal 2014; Stack, Walsh, Comber, Ryan & O'Lorcain 2007).  
Wilms' Tumour is a renal tumour that is usually unilateral in nature, but can occur bilaterally 
on rare occasions (Kaste, Dome, Babyn, Graf, Grundy, Godzinski, Levitt & Jenkinson 2008).  
It is a type of cancer found predominantly amongst young children and accounts for 
approximately 5% of all childhood cancers in developed countries (Ward et al 2014; Stack et 
al 2007).  In African countries it is the most commonly occurring solid tumour (Stefan 2015) 
and accounts for 12% of all childhood cancer cases recorded in South Africa (Stefan & 
Stones 2012).  Furthermore, Wilms' Tumour is one of the most common types of childhood 
cancer occurring in rural areas of South Africa‟s Eastern Cape Province (Somdyala, 
Bradshaw, Gelderblom & Parkin 2010). 
 
There is a paucity of information regarding the prevalence of cancer in children in developing 
countries as well as the prevalence of malnutrition in this population.  This is due to the 
under-diagnosis of paediatric cancers in these countries, as well as a lack of simple measures 
for recording and capturing patient related data, such as cancer registries (Stefan, Baadjes & 
Kruger 2014).  As is the case in most developing countries, children with Wilms' Tumour in 
South Africa face many challenges that can affect their prognosis.  These challenges include 
delayed presentation, high rates of treatment abandonment, poverty, as well as ignorance and 
lack of education amongst some communities (Paintsil, David, Kambugu, Renner, Kouya, 
Eden, Hesseling, Molyneux & Israels 2015; Wilde, Lameris, van Hasselt, Molyneux, Heij & 
Borgstein 2010; Abuidris, Elimam, Nugud, Elgaili, Ahmed & Arora 2008).  Disease stage 
and histology are considered to be the most important prognostic indicators amongst children 
with Wilms' Tumour.  Staging of the tumour occurs post-operatively, and stage of disease is 
determined by factors such as tumour extension beyond the kidney, presence of lymph nodes 
or metastases, tumour rupture or the presence of bilateral tumours. The histological 
classification of a tumour is dependent on the types of cells that are predominant in the 






„favourable‟ or „unfavourable‟ (Kaste et al 2008), depending on the type of cells, and 
predominance thereof, within the tumour (Poole 2010).  
 
Paediatric malnutrition is a widespread problem in both developing and developed countries.  
Worldwide, 15% of children are underweight and 25% are stunted [United Nations Children's 
Fund (UNICEF) 2015]. In sub-Saharan Africa, more than one fifth of all children are 
underweight, more than one third are chronically malnourished (stunted) and just under one 
tenth are acutely malnourished (wasted) (UNICEF 2015).  Three large studies have been 
conducted in South Africa in order to determine the prevalence of malnutrition amongst 
South African children.  The National Food Consumption Survey (NFCS), conducted in 
1999, showed the national prevalence of stunting, wasting and underweight to be 21.6%, 
3.7% and 10% respectively (Labadarios, Steyn, Maunder, MacIntyre, Swart, Gericke, 
Huskisson, Dannhauser, Voster & Nesamvuni 2000). The National Food Consumption 
Survey-Fortification Baseline (NFCS-FB) of 2005, showed a slight improvement in the 
prevalence of stunting and underweight (18% and 9.3%) and a slight deterioration in the 
prevalence of wasting (4.5%) (Labadarios, Swart, Maunder, Kruger, Gericke, Kuzwayo, 
Ntsie, Steyn, Schloss, Dhansay, Jooste, Dannhauser, Nel, Molefe & Kotze 2008).  The third 
survey, the South African National Health and Nutrition Examination Survey (SANHANES-
1), released in 2013, showed the lowest prevalence of stunting, wasting and underweight, at 
15.4%, 2.9% and 5.8% respectively (Shisana, Labadarios, Rehle, Simbayi, Zuma, Dhansay, 
Reddy, Parker, Hoosain, Naidoo, Hongoro, Mchiza, Steyn, Dwane, Makoae, Maluleke, 
Ramlagan, Zungu, Evans, Jacobs, Faber & SANHANES-1 Team 2013). 
 
Available studies have shown that 45-69% of children with cancer in developing countries 
are malnourished on admission to hospital (Sala, Rossi, Antillon, Molina, de Maselli, Bonilla, 
Hernandez, Ortiz, Pacheco, Nieves, Navarrete, Barrantes, Pencharz, Valsecchi & Barr 2012; 
Israels, Borgstein, Jamali, de Kraker, Caron & Molyneux 2009; Israels, Chirambo, Caron & 
Molyneux 2008).  Malnutrition amongst this population can lead to increased mortality and 
treatment abandonment rates (Sala et al 2012), as well as increased risk of complications 
(Murry, Riva & Poplack 1998).  Many risk factors for a poor outcome amongst children with 
cancer, such as age, are not modifiable.  Malnutrition, on the other hand, is a risk factor that 
can be modified if the correct steps are taken (Orgel, Sposto, Malvar, Seibel, Ladas, Gaynon 






Assessment of nutritional status of children with cancer needs to be standardised amongst 
centres treating these patients (Rogers, Melnick, Ladas, Halton, Baillargeon & Sacks 2008).  
Weight has commonly been used in isolation in order to classify nutritional status; however a 
growing body of research has emphasised the importance of including arm anthropometry 
measurements as part of the classification criteria for these patients (Israels et al 2008; Tazi, 
Hidane, Zafad, Harif, Benchekroun & Ribeiro 2008; Garofolo, Lopez & Petrilli 2005).  In 
order for nutritional intervention to be implemented, classification of nutritional status of 
children with cancer needs to be conducted as soon as possible after admission.  This will 
allow for malnourished children, or those at risk of becoming malnourished, to be identified.  
By reducing the time period that children are classified as being malnourished during their 
treatment period (for example, by implementing nutritional interventions as soon as possible 
after admission), the negative effects of poor nutritional status on admission can be 
significantly reduced (Orgel et al 2014). 
 
There is a paucity of data relating to children with cancer, and Wilms' Tumour in particular.  
Although some studies have found a significant correlation between malnutrition on 
admission and poorer outcome (Sala et al 2012; Mejia-Arangure, Fajardo-Gutierrez, Reyes-
Ruiz, Bernaldez-Rios, Mejia-Dominguez, Navarrete-Navarro & Martinez-Garcia 1999; 
Viana, Murao, Ramos, Oliveira, de Carvalho, de Bastos, Colosimo & Silvestrini 1994), 
others have failed to show any significant link between these two variables (Pedrosa, Bonilla, 
Liu, Smith, Davis, Ribeiro & Wilimas 2000; Wessels, Hesseling, Van Ommeren & Boonstra 
1999; Weir, Reilly, McColl & Gibson 1998).  Of further concern is the fact that many 
children in previous studies may have been incorrectly classified as being well-nourished 
when in fact they were malnourished (Lemos, de Oliveira & Caran 2014; Israels et al 2008; 
Tazi et al 2008). 
 
When weight and height are used in isolation in order to classify nutritional status, 
malnutrition in children with Wilms' Tumour can be masked (Lemos et al 2014; Israels et al 
2008; Tazi et al 2008) due to factors such as tumour mass and fluid shifts (Rogers 2014).  In 
addition to these, utilisation of serum albumin as an indicator of nutritional status can also 
lead to underestimation of the prevalence of malnutrition when used in isolation.  This is 
because albumin levels can be affected by several disease-related factors, thereby limiting its 






in the past used weight, height and Body Mass Index (BMI), or serum albumin levels, in 
isolation in order to classify nutritional status (Burke, Lyden, Meza, Ladas, Dasgupta, 
Wiegner & Arndt 2013), it can be posited that the rates of malnutrition amongst Wilms' 
Tumour patients could have been under-reported, leading to a significant underestimation of 
the actual prevalence of malnutrition amongst this population to date.  Arm anthropometry, 
specifically MUAC and TSFT, should be incorporated in order to accurately classify their 
nutritional status (Sala et al 2012) as these measures are independent of tumour size (Tah, 
Nik Shanita & Poh 2012; Brennan, Gill, Pennells, Eden, Thomas & Clayton 1999).  
Utilisation of biochemistry (namely serum albumin) and anthropometry measurements in 
combination has been shown to improve the sensitivity of classification of nutritional status 
(Sala et al 2012). 
 
Nutritional intervention amongst children with cancer has been shown to be effective in 
improving nutritional status (Holzinger, Shaik & Hadley 2007).  However, implementation of 
nutritional assessments and interventions in centres treating children with cancer, both 
internationally and in South Africa, is erratic and lacks standardisation (Schoeman 2011; 
Ladas, Sacks, Brophy & Rogers 2006).  Inkosi Albert Luthuli Central Hospital (IALCH) is a 
Durban-based hospital and is classified as a National Central Hospital which services all of 
South Africa as well as patients from neighbouring countries on occasion.  On a tertiary level, 
IALCH serves as a referral hospital for patients residing throughout KwaZulu-Natal (KZN) 
and the seaboard areas of the Eastern Cape (Department of Health 2014).  This study took 
place between 2004 and 2012.  During this time, IALCH was the only state-run hospital 
treating children with Wilms‟ Tumour in the KZN province. Each subject admitted between 
2004 and 2012 was followed up for a period of two years from the date of admission to 
IALCH.  A local study, which assessed prevalence of malnutrition but not the effect thereof 
on outcome, showed that 45% of patients admitted to IALCH with Wilms' Tumour were 
malnourished on admission.  Furthermore, these authors showed that nutritional intervention, 
in the form of oral and enteral supplementation, leads to significant improvement in 
nutritional status amongst these subjects (Holzinger et al 2007). 
 
There is a dearth of data analysing the influence of nutritional status on outcome amongst 
children with Wilms' Tumour internationally and in South Africa.  This study was important 






admission to hospital.  Furthermore, it was important in order to determine the influence of 
nutritional status at the time of admission on disease outcome amongst a sample whose 
nutritional status had been accurately classified. 
 
The following questions therefore arise: 
 What is the prevalence of malnutrition amongst children with Wilms‟ Tumour on 
admission to a South African hospital? 
 Does nutritional status on admission influence the outcome after two years amongst 
children with Wilms‟ Tumour? 
 What level of nutritional support was prescribed to children with Wilms‟ Tumour 
within the first two weeks of admission to IALCH during the study period? 
 
This study was necessary as it would serve to provide important baseline data in an area that 
has not been widely researched.  It was anticipated that the results of this study would help to 
establish the prevalence of malnutrition amongst this population when admitted to hospital 
and the influence thereof on outcome.  Due to the fact that IALCH serves patients spanning 
two provinces, it was thought that the results of this study could be applied to a wide variety 
of South Africans with potentially diverse socioeconomic backgrounds and environments.  
By understanding the influence of nutritional status on disease outcome, it was anticipated 
that this would help to better define the role of nutritional intervention and support amongst 
this population, as well as to improve the efficacy thereof.  Furthermore, this study would 
help to emphasise the importance of standardisation, with regards to classification methods, 
when assessing nutritional status amongst this population.   
 
1.2. Statement of the problem 
The purpose of this study was to determine the prevalence of malnutrition amongst children 
with Wilms‟ Tumour on admission to IALCH.  Furthermore, it aimed to determine the 
correlation between nutritional status on admission and outcome, as well as to determine the 








1.3. Research objectives 
The objectives of this study were: 
1.3.1 To determine the prevalence of malnutrition using a combination of anthropometric 
and biochemical markers, defined by the Asociación de Hemato-Oncología Pediátrica 
de Centro América (AHOPCA) algorithm. 
1.3.2 To determine the influence of nutritional status on admission on the outcome, in terms 
of overall survival and death, amongst children with Wilms' Tumour admitted to 
IALCH between 2004 and 2012. 
1.3.3 To determine the level of nutritional support prescribed to children with Wilms‟ 
 Tumour within the first two weeks of admission to IALCH between 2004 and 2012. 
 
1.4. Hypotheses 
1.4.1 The utilisation of weight, height and albumin in isolation would underestimate the 
 prevalence of malnutrition. 
1.4.2  The use of arm anthropometry in combination with albumin would give a more 
 accurate result regarding the prevalence of malnutrition. 
1.4.3  The overall outcome, in terms of survival, of subjects who were malnourished on 
admission would be lower compared to those who were well nourished on admission.   
 
1.5. Inclusion and exclusion criteria 
This study was limited to: 
 Children up to the age of 13 years old who were admitted to the paediatric surgery 
ward at IALCH hospital and diagnosed with Wilms' Tumour between 2004 and 2012. 
 Children whose anthropometric measurements were taken by registered dietitians. 
 Children whose nutritional status was classified based on weight, height, MUAC, 
TSFT and biochemical measurements taken on admission to hospital, before the 
initiation of the treatment course (chemotherapy, radiotherapy and/or surgery). 
 
This study excluded: 
 Children whose anthropometric and biochemical measurements were taken after 






 Children whose initial anthropometric and biochemical measurements were taken at a 
follow up admission (in other words, not on the admission when they were initially 
diagnosed with Wilms' Tumour). 
 
1.6. Definition of terms 
Basal Metabolic Rate:   The minimal energy expended for the maintenance of respiration, 
circulation, peristalsis, muscle tonus, body temperature, glandular 
activity, and other vegetative functions of the body‟ (Block, John, 
Borer, Pucci, Bruce, Silver, Christopher, Drake, Vogl, Jangid & 
Whitman 2007, p1159). 
 
Body Mass Index:   
 
The BMI gives a representation of a person's weight in relation to 
their height in order to classify their nutritional status.  It is 
calculated using weight, in kilograms, divided by the square of a 
person‟s height, in metres (Stedman 2005, p193). 
 
Children with Wilms' 
Tumour: 
For the purpose of this study, this was defined as patients up to the 
age of 13 years, who had been diagnosed with Wilms‟ Tumour 
after undergoing a biopsy.  
 
Malnutrition:   For the purpose of this study, children were classified as 
malnourished if at least one of these criteria were fulfilled:   
 MUAC and TSFT between the fifth and tenth percentiles 
 MUAC less than the fifth percentile and TSFT more than 
the tenth percentile 
 MUAC more than the tenth percentile and TSFT less than 
the fifth percentile 
 Albumin less than 35g/L 
Those who met at least one of the following criteria were classified 
as severely malnourished: 
 MUAC and/or TSFT below the 10th centile 







Mid Upper Arm 
Circumference:   
An anthropometric measurement used for classification of 
nutritional status and 'the best anthropometric predictor of 
mortality currently available' (Walters, Sibson & McGrath 2012). 
 
Outcome:   For the purposes of this study, outcomes were described in terms of 





An anthropometric measurement which is taken at the mid-point of 
the child's upper arm.  'A skinfold is held between the investigator's 
thumb and index finger (subcutaneous fold without muscle).  The 
caliper is placed about 1 mm below the left hand, perpendicular to 
the skinfold.  The right hand holds the caliper and the measurement 
is read within 3 seconds (so that pressure does not compress the 
subcutaneous tissue)' (Hall, Allanson, Gripp & Slavotinek 2007, 
p67). 
 
Tumour burden The amount of a subject‟s weight that is attributed to the mass of 
their tumour.  The mass of the tumour can be determined by 
weighing the tumour after it has been surgically removed. 
 
Wilms' Tumour:   Also known as Nephroblastoma.  'A malignant tumour of the 
kidney; occurs almost exclusively in children.  Thought to develop 
from embryonic structures' (Freshwater & Maslin-Prothero 2005, 
p384).   
 
1.7. Abbreviations 
AHOPCA:  Asociación de Hemato-Oncología Pediátrica de Centro América 
BMI:     Body Mass Index 
COG:   Children's Oncology Group 
HFA:   Height for Age 






KZN:   KwaZulu-Natal 
MUAC:    Mid Upper Arm Circumference 
TSFT:    Triceps Skinfold Thickness 
WFA:   Weight for Age 
WFH:   Weight for Height 
WHO:   World Health Organization 
UNICEF:  United Nations Children's Fund  
 
1.8. Assumptions 
The following assumptions were made: 
 All dietitians who took the anthropometric measurements (weight, height, MUAC and 
TSFT) did so accurately and as per the standard practices at IALCH.  
 Biochemical measurements were taken and analysed accurately.  
 Patient records accurately reflected nutritional interventions undertaken for each 
patient. 
 Progression of cancer stages amongst individuals with Wilms‟ Tumour was not 
generalizable, and may have been influenced by factors such as histology, genetics 
and environmental influences. 
                                                                                                                           
1.9. Summary 
Studies have shown that childhood cancer is a serious and relevant problem affecting children 
both internationally and in South Africa.  Studies have found that 45-69% of children with 
cancer in developing countries are malnourished, and the prevalence of malnutrition amongst 
children with Wilms' Tumour in KZN has been shown to be similarly high.  However, many 
previous studies potentially underestimated the prevalence of malnourished children in their 
samples due to inaccurate classification of nutritional status.  Some studies analysing children 
with cancer have found malnutrition on admission to hospital to be a poor prognostic 
indicator, while others have not been in agreement.  In general, there is a serious dearth of 
studies conducted on children with Wilms' Tumour, with only a few having taken place in a 







It was anticipated that this study would provide an accurate indication of the prevalence of 
malnutrition amongst children with Wilms' Tumour presenting to IALCH between 2004 and 
2012, as well as to describe the influence of nutritional status at the time of admission on 
outcome.  Furthermore, it was anticipated that this study would shed light on the dietary 
interventions received amongst this sample in a South African setting, consequently helping 
to improve medical and nutritional management of this population group in the future.  This 
study did not address the influence of type and duration of treatment on nutritional status or 
outcome of the subjects. 
 
1.10. Dissertation overview 
This dissertation consists of six chapters.  The first chapter addresses the reasons why such an 
investigation is relevant and necessary, and presents the study objectives.  The second chapter 
discusses the current literature regarding paediatric nutritional status, paediatric cancer and 
the role of dietary intervention amongst this population.  The third chapter discusses the 
methodology utilised in the study, while the fourth chapter presents the results after the 
statistical analyses were conducted.  Chapter five discusses the results of this study in relation 
to the literature discussed in chapter two.  Finally, chapter six concludes the dissertation and 
provides recommendations for future research based on the results obtained. 
 
1.11. Referencing style 
This dissertation has been written using the referencing style of the Discipline of Dietetics 







CHAPTER 2: REVIEW OF THE RELATED LITERATURE 
 
In order to facilitate a better understanding of the problem at hand, this chapter will review 
the literature relating to children with cancer as well as paediatric malnutrition.  The first 
section will delve into the background relating to paediatric cancer and paediatric 
malnutrition.  It will discuss the prevalence, treatment, survival, prognostic indicators and 
challenges associated with paediatric cancer patients, focusing specifically on developing 
countries.  The second section will focus on nutritional assessment utilising both 
anthropometric and biochemical measurements, methods of classifying nutritional status and 
problems associated therewith.  The third section will focus on the pathogenesis of 
malnutrition amongst children with cancer, including cancer cachexia, as well as examine the 
relationship between nutritional status and outcome.  In addition, it will assess the role of 
nutritional intervention in the treatment and management of this population. 
 
2.1. Childhood cancer 
The incidence of types of cancer amongst adolescents and children varies by age.  Wilms' 
Tumour, also known as Nephroblastoma, is a type of cancer that contributes to approximately 
five percent of all childhood cancer cases in developed countries (Ward et al 2014; Stack et 
al 2007).  It is not commonly seen in children older than ten years of age (Steliarova-Foucher, 
Stiller, Kaatsch, Berrino, Coebergh, Lacour & Parkin 2004).  In Europe, Wilms' Tumour is 
the eighth most commonly occurring cancer amongst children from birth to 14 years of age, 
constituting 5.7% of all paediatric cancers between 1978 and 1997 (Magnani, Pastore, 
Coebergh, Viscomi, Spix, Steliarova-Foucher 2006).  Figure 2.1 shows the prevalence of the 







Figure 2.1:  Estimated prevalence of childhood cancers among American children between 
0 and 14 years of age (Ward et al 2014) 
 
Data on the prevalence of paediatric cancers in developing countries is lacking.  This is due 
to factors such as the under-diagnosis of paediatric cancers, as well as a lack of simple 
measures for recording and capturing patient related data, such as cancer registries (Stefan et 
al 2014).  The only known tumour registry in Africa dedicated solely to the documentation of 
paediatric cancer was developed by the South African Children's Cancer Study Group and 
has been in place for more than 25 years (Stefan & Stones 2012).  A recent survey has shown 
that Wilms' Tumour accounts for more than 10% of childhood cancers in many African 
countries.  In certain African countries the prevalence was found to be more than four times 
higher than that of developed countries (Stefan 2015).  In South Africa, Wilms' Tumour 
patients account for 12% of paediatric cancer cases, making it the fourth most common 
cancer amongst this population (Stefan & Stones 2012).  In rural areas of the Eastern Cape, 
the prevalence of paediatric cancer has been shown to be 2.8% of all cancers, with Wilms' 
Tumour and brain tumour being the most common types (Somdyala et al 2010).  Wilms' 
Tumour remains the most predominant solid tumour in African countries (Stefan 2015). 
 
2.1.1. Diagnosis of Wilms' Tumour 
If a child is suspected to have Wilms' Tumour, a series of tests and investigations are carried 























distended abdominal veins.  Immediate investigations include blood and urine tests, as well 
as a chest X-ray.  An ultrasound is considered to be compulsory as part of the investigations 
of these patients, and doctors may deem it necessary to perform a Computed Tomography 
(CT) scan of the abdomen.  Finally, a biopsy is performed in order to confirm diagnosis of 
Wilms' Tumour (Poole 2010). 
 
2.1.2. Factors affecting prognosis in developing countries  
In general, stage and histology are considered to be the most important factors influencing the 
prognosis of children with Wilms' Tumour (Kaste et al 2008).  However, when compared to 
developed countries, poorer outcomes have been observed amongst paediatric oncology 
patients in developing countries due to a variety of factors (Figure 2.2) (Paintsil et al 2015; 
Wilde et al 2010; Abuidris et al 2008). 
  
 







Late presentation, in particular, is a common problem in this setting (Paintsil et al 2015; Yao, 
Li, Xiao, Gao, Dong, Xiao & Lv 2012; Wilde et al 2010; Abuidris et al 2008; Ekenze, 
Agugua-Obianyo & Odetunde 2006), and can often be exacerbated by poverty and ignorance 
(in the form of lack of education) amongst some communities (Stones, de Bruin, Esterhuizen 
& Stefan 2014; Yao et al 2012).  In a Nigerian hospital, Ekenze et al (2006) found that, on 
average, their patients presented after almost five months of displaying symptoms of Wilms' 
Tumour.  Consequently, the majority of their sample presented in the later stages of disease 
(stage three and four), while no patients presented in the initial stage of disease (stage one).  
In a study conducted by Abuidris et al (2008) in Sudan, 78.4% of their Wilms' Tumour 
patients presented in stage three or four.  A local study conducted in KZN showed that 
children from rural areas presented to hospital with Wilms' Tumour later than children from 
urban areas.  Furthermore, the children from rural areas were more likely to present with 
larger tumour masses and a more advanced stage of disease (Hadley & Jacobs 1990).  Israels 
et al (2009), who conducted a similar study in a hospital in Malawi, found that children with 
larger tumours were more likely to be malnourished. 
 
Treatment-related problems provide further challenges which can contribute to poor outcome 
amongst this population (Paintsil et al 2015; Ekenze et al 2006).  Treatment abandonment 
poses a particular problem (Madani et al 2006), with as many as 48% of patients in countries 
in the sub-Saharan Africa region failing to complete their treatment programmes (Paintsil et 
al 2015).  Figures for abandonment have been shown to be as high as 62% amongst children 
with Wilms' Tumour (Abuidris et al 2008).  In developing countries, many patients abandon 
treatment due to financial constraints, as some of the treatments and drugs are not subsidised 
(Abuidris et al 2008; Ekenze et al 2006).  Severe poverty, which is present in many 
developing countries, means that caregivers are often unable to afford the costs of travelling 
to and from the hospital for treatment, as well as the cost of lodging and food during the 
hospital stay, further contributing to high rates of treatment abandonment.  A study conducted 
by Abuidris et al (2008) showed that for various reasons, including financial constraints, only 
11% of their sample of Wilms' Tumour patients completed the treatment programme, while 
27% received no treatment whatsoever.  The average cost of treating a Wilms' Tumour 
patient in Sudan, for example, can be as high as US$8901 (R12 255) (Abuidris et al 2008).  In 
South Africa, the cost of treating Wilms' Tumour patients in public hospitals according to the 
                                                 






Societe Internationale d'Oncologie Pediatrique (SIOP) treatment protocols can exceed 
US$5000 (R68 850) depending on the stage of disease (Stefan, Stones, van Zyl & Uys 2014).  
The majority, if not all, treatment at IALCH is subsidised by the government, depending on 
parental income (Department of Health, Western Cape Government 2015). 
 
Factors shown to significantly increase the rate of treatment abandonment include living far 
from the treatment facility (Slone, Chunda-Liyoka, Perez, Mutalima, Newton, Chintu, 
Kankasa, Chipeta, Heimburger, Vermund & Friedman 2014), severity of malnutrition at 
diagnosis (Antillon, Rossi, Molina, Sala, Pencharz, Valsecchi & Barr 2013; Sala et al 2012) 
and poor maternal education (Slone et al 2014; Abuidris et al 2008; Ekenze et al 2006).  
After chemotherapy and surgery, many parents may assume that their child is cured in light 
of the fact that symptoms such as abdominal distension have resolved, and do not understand 
the need for returning to the hospital in order for treatment to be completed (Abuidris et al 
2008).  In addition to this, many drugs are simply unavailable in resource-limited countries 
(Wilde et al 2010; Ekenze et al 2006). 
 
2.1.3. Treatment guidelines for patients in resource limited settings 
A group of experts have developed guidelines specifically for the treatment of children with 
Wilms' Tumour in resource limited settings, based on guidelines developed by the SIOP in 
2001.  Wilms' Tumour can be diagnosed using ultrasonography, while minimum treatment 
for curative intent in these settings involves pre- and post-operative chemotherapy as well as 
surgical resection of the tumour.  When available and when necessary, radiotherapy can be 
used as an adjunct to the above therapies.  However, it is not considered to be absolutely vital 
for the curative treatment of these patients.  Both social and financial support, including 
extensive counselling, should be provided to the families of patients in order to ensure 
treatment compliance and prevent treatment abandonment (Israels, Moreira, Scanlan, 








2.1.4. Survival in developed versus developing countries 
Paediatric cancers have been prevalent for decades and, in both developed and developing 
countries, the overall incidence has continued to increase (Ward et al 2014; Steliarova-
Foucher et al 2004; Chintu, Athale & Patil 1995).  Survival, on the other hand, has shown 
significant improvement over the years, due to factors such as increasingly advanced 
treatment and improved management of patients (Ward et al 2014; Kaste et al 2008; 
Steliarova-Foucher et al 2004).  Furthermore, the establishment of multi-disciplinary co-
operative groups, such as the Children's Oncology Group (COG) and SIOP, involving 
collaboration amongst experts on a national and international level has also contributed to the 
improved survival rates (Kaste et al 2008). 
 
Death rates amongst this population have declined by more than 50% in America.  
Furthermore, in the case of several types of cancer, including Wilms' Tumour, those who 
survive more than five years have been shown to have a favourable chance of long-term 
survival (Ward et al 2014).  Wilms' Tumour patients in America have seen five year survival 
rates improve from 73% in the 1970s to 93% between 2005 and 2011 (SEER Cancer 
Statistics Review 1975-2011).  Similarly, since 1978 steady improvements in the five year 
survival rates of European children with renal tumours have also been observed (Magnani et 
al 2006).  However, survival rates in developing countries are significantly worse, especially 
in the region of sub-Saharan Africa.  In South Africa, five year survival rates of children with 
Wilms' Tumour have been shown to be just over 60%, while the overall survival rate of 
children with cancer is 52% (Stones et al 2014).  In other developing countries, however, 
survival rates can fall as low as 11% (Paintsil et al 2015; Abuidris et al 2008) while the 
average short-term survival rate in sub-Saharan Africa (SSA) is 39% (Paintsil et al 2015).  
Children of Black ethnic origin have been shown to have significantly poorer survival rates 
than those of other ethnic origins (Stones et al 2014). 
 
2.1.5. Malnutrition at diagnosis in developing countries  
The prevalence of malnutrition amongst paediatric cancer patients in developing countries 
has been shown to range from 45-77% (Sala et al 2012; Israels et al 2009; Israels et al 2008; 
Garofolo et al 2005).  Given the high prevalence of paediatric malnutrition in South Africa, 






previously, a similar prevalence would be expected amongst South African children with 
Wilms' Tumour. In KZN in particular, more than twice as many children from rural areas 
were shown to present to hospital in a malnourished state in comparison to their urban 
counterparts (Hadley & Jacobs 1990).  Furthermore, in this province malnutrition has been 
shown to occur in almost half of Wilms' Tumour patients on admission to hospital (Holzinger 
et al 2007). 
 
Other issues that are cause for concern amongst children with Wilms‟ Tumour in developing 
countries include the fact that children with larger tumours on admission have been shown to 
be more severely malnourished than those with smaller tumours (Israels et al 2009).  
Furthermore, according to several studies children with solid tumours are more likely to be 
malnourished (Murphy, White & Davies 2009; Tazi et al 2008; Brennan et al 1999), and 
present with increased severity of malnutrition compared to those with haematological 
tumours (Garofolo et al 2005).  Additionally, the intake of the majority of nutrients can be 
significantly lower in children with solid tumours compared to haematological malignancies 
(Tah et al 2012).  Factors that could contribute to the development of malnutrition amongst 
these children include insufficient dietary intake as well as the effect of the prolonged 
presence of malignant disease due to delayed presentation to hospital (Israels et al 2009).  
Therefore it is important to emphasise the importance of nutritional assessment amongst this 
population in order to detect patients who are malnourished, or at risk of becoming 
malnourished, on admission.  This will allow for the necessary nutritional rehabilitation to 
take place as soon as possible after admission to hospital.  The assessment of nutritional 
status amongst children with cancer will be discussed in the following section.   
 
2.2. Nutritional assessment of children with cancer 
Poor nutritional status can contribute to increased mortality rates as well as an increased rate 
of treatment abandonment (Sala et al 2012).  Furthermore, it can lead to an increased risk of 
complications and can impact the absorption, excretion and metabolism of anti-neoplastic 
drugs that the majority of children with cancer receive (Murry et al 1998).  The classification 
of nutritional status should therefore be considered as an integral part of every child's initial 
assessment on admission to hospital for cancer treatment and management (Lemos et al 






2.2.1. Methods used to assess nutritional status 
There are several methods available to classify nutritional status amongst the paediatric 
population.  Weight, height and BMI are commonly used to classify nutritional status 
(Murphy et al 2009; Ladas et al 2006) as they are affordable, easy and quick anthropometric 
measurements that can be performed by most staff at a health facility (Orgel et al 2014).  
However, studies have shown that when weight and height are used in isolation in order to 
classify nutritional status, malnutrition in children with Wilms' Tumour can be masked 
(Lemos et al 2014; Israels et al 2008; Tazi et al 2008) because of factors such as tumour mass 
and fluid shifts (Rogers 2014).  This can lead to many malnourished patients being 
incorrectly classified as well-nourished (Lemos et al 2014; Israels et al 2008; Tazi et al 
2008).  Due to the fact that many studies in the past used only weight, height and BMI to 
classify nutritional status (Burke et al 2013), it is possible that the rates of malnutrition 
amongst Wilms' Tumour patients could have been under-reported, leading to a significant 
underestimation of the actual prevalence of malnutrition amongst this population to date. 
 
The term corrected weight refers to the weight of a subject when tumour weight (obtained 
post-operatively) is subtracted from admission weight.  This has been used previously (Israels 
et al 2009) and may provide a more accurate indication of nutritional status when weight and 
height measurements are used.  However, corrected weight should not be considered to be an 
accurate reflection of nutritional status in isolation, as the tumour weight at the time of 
surgery is usually smaller than on admission due to the provision of pre-operative 
chemotherapy (Israels et al 2009).  Murphy et al (2009) emphasised that height, weight and 
BMI should only be used in order to screen patients initially and should not be considered a 
comprehensive or accurate method of classifying nutritional status amongst this population.  
The authors emphasised that the incorrect classification of malnourished children as "well-
nourished" can lead to a worsened prognosis (Murphy et al 2009). 
 
2.2.2. Arm anthropometry 
Arm anthropometry, specifically MUAC and TSFT, should be incorporated in the nutritional 
assessment of children with Wilms' Tumour in order to accurately classify their nutritional 
status (Sala et al 2012).  These measures are independent of tumour size (Tah et al 2012; 






conduct (Hoffmeister, Storer, Macris, Carpenter & Baker 2013).  Both MUAC and TSFT 
have been shown to be feasible tools for classification of nutritional status in developing 
countries in particular (Sala et al 2012; Garofolo et al 2005).  MUAC provides a measure of 
body fatness, while TSFT measures muscle mass (Ramsey, Farrell & Pencharz 1992).  
MUAC measurements have the added advantage of being less severely affected by fluid 
shifts compared to TSFT measurements (Tah et al 2012). 
 
Tazi et al (2008) demonstrated the discrepancies that can transpire when using weight and 
height alone in order to assess nutritional status.  In a sample of 100 children with cancer, 
37% and 20% of children were classified as being malnourished when utilising weight- and 
height-for-age measurements respectively.  However, when arm anthropometry was included 
as part of the anthropometric assessment, the prevalence of malnutrition was noted to be as 
high as 50%.  The same trend was observed in a much larger study involving 1787 children 
with cancer conducted by Sala et al (2012).  In this study, the prevalence of malnutrition 
increased from 28% when BMI was used, to 63% when arm anthropometry was included in 
the anthropometric assessment.  Similar evidence for the superior accuracy of arm 
anthropometry compared to weight, height and BMI amongst this population has been 
demonstrated in several other studies discussed in Table 2.1 (Israels et al 2008; Tazi et al 






Table 2.21: Studies assessing the most accurate methods of classifying nutritional status amongst children with cancer 
Study Objectives Subjects Methods Results Limitations Conclusion 
Nutritional status at 
admission of children 
with cancer in 
Malawi. 
 
Israels et al (2008) 
 
Location:  Malawi 






128 children  
1-16 years 
 
HM = 74.2% 
















HFA = 44.5% 
WFA = 39.8% 
WFH = 17.2% 
AMA = 55.1% 
TSFT + MUAC  = 
59.3% 
TSFT + MUAC > 






Malnutrition was common 
amongst this population on 
admission to hospital. 
 
AA was a more sensitive 
measure of nutritional 
status. 
Nutritional status at 
diagnosis of children 
with malignancies in 
Casablanca. 
 
Tazi et al (2008) 
 
Location:  Morocco 
 
 




with cancer at 
diagnosis. 
100 children 
under the age of 
18 years 
 
HM = 58 
ST = 38 
















 WFA = 37% 
 HFA = 20% 
 BMI = 33% 
 TSFT = 50% 
 MUAC = 39% 
 AMC = 42% 










High prevalence of 
malnutrition amongst 
children with cancer at 
diagnosis. 
 
AA was a more sensitive 
measure of nutritional 
status, especially for 








Table 2.1  Continued 
Study Objectives Subjects Methods Results Limitations Conclusion 
High prevalence of 
malnutrition among 
patients with solid 
non-haematological 
tumors as found by 




Garofolo et al (2005) 
 








with ST versus 
HM. 
127 children  
 
HM = 59 














malnutrition -  
HM vs. ST: 
WFH/BMI = 6.8 vs. 
29.4%  
MUAC = 25.4 vs. 
44.1% 
TSFT = 33.9 vs. 
45.6% 





TSFT = 40.2% 
MUAC = 35.4% 
WFH/BMI = 18.9% 
Small sample 
size 
Malnutrition was common 
amongst this population. 
 
Children with ST were 




were not sensitive 
measures of malnutrition 




AA Arm Anthropometry HM Haematological Tumours 
ALL Acute Lymphoblastic Leukaemia MUAC Mid Upper Arm Circumference 
AMA  Arm Muscle Area ST  Solid Tumours 
AMC Arm Muscle Circumference TSFT Triceps Skinfold Thickness 
BMI Body Mass Index WFA  Weight for Age 
EFS Event Free Survival WFH  Weight for Height 







One of the criteria often used as part of the nutritional assessment of children with cancer is serum 
albumin levels (Sala et al 2012; Tah et al 2012; Israels et al 2009; Murphy et al 2009; Elhasid, 
Laor, Lischinsky, Postovsky & Weyl Ben Arush 1999).  Albumin is a protein that is synthesised in 
the liver, and measurement thereof can give an indication of visceral protein status (Brennan 1998).  
When used in isolation, measurement of serum albumin is considered by many to be an unreliable 
indicator of nutritional status due to the wide spectrum of factors that can influence albumin status 
(Tazi et al 2008).  Albumin levels can appear elevated due to factors such as dehydration or 
corticosteroid treatment, whereas levels can decrease in response to inflammation, malabsorption 
and liver disease (Fuhrman 2002).  Furthermore, the fact that it is a negative acute phase protein 
means disease-related factors such as temperature can affect albumin levels (Brennan 1998).  It also 
has a long half-life of approximately 20 days (Fuhrman 2002). 
 
Nonetheless, albumin does have a place in the nutritional assessment of patients (Ladas et al 2006).  
Albumin has been shown to be a very useful measure in combination with anthropometric 
measurements, as it improves the sensitivity of nutritional classifications (Sala et al 2012).  
Albumin is considered to be low when levels fall below 35g/l (Heber, Greenway, Kaplan, 
Livingston, Salvador & Still 2010).  In a study of 1513 children with cancer in developing 
countries, Sala et al (2012) showed that the inclusion of albumin as a criterion for the classification 
of nutritional status added considerable value.  When comparing classifications using measurements 
of arm anthropometry alone (MUAC and TSFT) to measurements including both arm 
anthropometry and albumin, those classified as severely malnourished increased from 45% to 59%.   
 
2.2.4. Current practices and the lack of a gold standard 
A significant problem associated with determining the prevalence of malnutrition is that there is no 
gold standard to accurately assess nutritional status amongst children with cancer (Burke et al 2013; 
Rogers & Ladas 2011; Israels et al 2008; Elhasid et al 1999), which route of feeding to choose and 
when to initiate nutritional interventions (Ladas et al 2006). 
 
The COG conducted an international survey amongst 125 institutions treating paediatric oncology 






population.  Of concern was the fact that this survey showed there was no uniform protocol being 
exercised amongst the institutions surveyed.  Just over half of the institutions had specific criteria 
for conducting nutrition interventions, while only 46% of children underwent a nutritional 
assessment on admission.  The majority of institutions utilised weight and height as their primary 
tools for classification of nutritional assessment, while only five percent included MUAC and TSFT 
measurements (Ladas et al 2006).   
 
An unpublished survey of eight South African paediatric oncology units conducted by Schoeman 
(2011) showed a similar lack of uniformity with regards to management of these children.  
Nutritional assessment on admission was not routinely conducted at all units and different 
assessment tools were used.  Furthermore, only 62% of units utilised MUAC as part of their 
nutritional assessments, while only 37% included measurements of TSFT.  According to the COG, 
current nutrition related practices amongst this population are based on opinions instead of 
evidence-based protocols (Rogers et al 2008). 
 
In order to try to standardise assessment and classification of nutritional status amongst children 
with cancer, an algorithm for nutritional classification and support was developed at a meeting held 
by the AHOPCA consortium.  The algorithm is based on data gathered from seven developing 
countries and incorporates arm anthropometry, albumin, weight loss and percentage of ideal body 
weight measurements as classification criteria (Sala et al 2005).   
 
According to the algorithm, adequately nourished subjects are those whose weight is more than 
90% of their ideal body weight (IBW), with albumin above 35g/L, MUAC and TSFT more than the 
10th centile and having experienced weight loss of less than 5% of their body weight.  They need to 
meet all of these criteria in order to be classified as adequately nourished.  According to this 
classification, those who are considered to be mildly malnourished based on MUAC and TSFT, are 
classified as adequately nourished if they meet all of the other criteria mentioned above.  Subjects 
are classified as being depleted (malnourished) if at least one of the following criteria are met: they 
are 60-89% of their IBW, their TSFT and/or MUAC is between the 5th and 10th centile, they have 
experienced weight loss of 5-10%, or their albumin is between 32 and 35g/L.  Severely 
malnourished subjects are those who are either less than 60% of their IBW, have a MUAC and/or 
TSFT below the 10th centile, have experienced more than 10% weight loss or have an albumin level 







Initially, the algorithm stated that both MUAC and TSFT had to be below a certain value in order 
for a subject to be classified as malnourished.  These criteria have since changed, stipulating that all 
subjects with either MUAC or TSFT below a certain level be classified as malnourished.  This was 
done in order to increase the sensitivity of the algorithm and to encourage interventions amongst a 
larger proportion of subjects (Sala et al 2005). 
 
2.3. Pathogenesis of malnutrition and the role of nutritional intervention 
In order to formulate effective and appropriate nutritional protocols and interventions amongst 
children with cancer, it is imperative to understand the causes and mechanisms underlying the 
development of their malnutrition.  Malnutrition is defined as a state of disequilibrium caused by an 
imbalance between the intake and loss of substrates (Mora 1999).  When the body experiences a 
prolonged period of starvation, an adaptive response occurs.  This leads to changes in hormone 
levels and, consequently, a reduction in the metabolic rate.  Furthermore, fat is utilised for fuel in 
order to preserve lean body mass, thereby prolonging survival (Bines & Heine 2005, p180).   
 
Unfortunately, the development of malnutrition amongst cancer patients is often more complicated 
than this.  A culmination of several underlying mechanisms can sometimes lead to a phenomenon 
involving anorexia, severe weight loss and muscle wasting, known as cancer cachexia (Fearon, 
Strasser, Anker, Bosaeus, Bruera, Fainsinger, Jatoi, Loprinzi, MacDonald, Mantovani, Davis, 
Muscaritoli, Ottery, Radbruch, Rovasco, Walsh, Wilcock, Kaasa & Baracos 2011).  This section 
will look at factors that can contribute to the development of malnutrition amongst children with 
cancer, with specific focus on cancer cachexia.  The relationship between nutritional status on 
admission and outcome, as well as the role of nutritional intervention amongst this population will 
also be discussed. 
 
2.3.1. Anorexia and reduced oral intake 
Studies have shown that children undergoing chemotherapy often fail to meet their nutritional 
requirements for all macronutrients (Skolin, Axelsson, Ghannad, Hernell & Wahlin 1997) due to 
insufficient dietary intake, leading to the development of malnutrition (Skolin, Wahlin, Broman, 






conducted a study on 22 children undergoing chemotherapy to assess which factors negatively 
influenced dietary intake.  Although the sample size was small, the authors found that altered taste 
and learned food aversions were the two most common side-effects that led to reduced oral intake.  
Children also experienced vomiting, nausea and mouth sores.  Furthermore, these children showed 
signs of physiological taste alterations with significantly higher sensitivity to bitter tastes and an 
impaired ability to correctly identify tastes (Skolin et al 2006).  Other factors that can contribute to 
reduced oral intake include mucositis, tension between children and their caregivers regarding 
eating, tumour burden and cancer cachexia (Burke et al 2013).  The tumour burden is the amount of 
the subject‟s weight that is attributed to tumour mass, and can be determined after surgery once the 
tumour has been removed.  Lastly, impaired gastrointestinal motility can cause early satiety, thereby 
limiting oral intake (Fearon et al 2011). 
     
2.3.2. Increased Basal Metabolic Rate 
It is thought that the disease process itself plays a role in the progressive development of  
malnutrition amongst children with cancer (Israels et al 2009) over and above factors contributing 
to reduced dietary intake as discussed earlier (Skolin et al 2006).  This could be attributed to the 
fact that metabolic alterations occur in many patients with cancer (Den Broeder, Oeseburg, Lippens, 
van Staveren, Sengers, van‟t Hof & Tolboom 2001).  Holroyde, Gabuzda, Putnam, Paul & Reichard 
(1975) showed that patients with metastatic disease exhibited increased energy expenditure due to 
altered glucose metabolism and subsequent increases in Cori cycle activity, which contributed to 
progressive weight loss. Furthermore, children with solid tumours were shown to have an increased 
Basal Metabolic Rate (BMR).  For some patients, this increased BMR may resolve after the first or 
second chemotherapy treatment (Den Broeder et al 2001). 
 
2.3.3. Cancer cachexia 
When reduced oral intake and anorexia occur in combination with increased metabolic demands, 
the development of malnutrition in children with cancer can often be attributed to a debilitating 
syndrome called cancer cachexia.  An international consensus defined cancer cachexia as "a 
multifactorial syndrome characterised by an ongoing loss of skeletal muscle mass (with or without a 
loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to 






mass is devastating for the cancer population in particular, as it has been shown to be associated 
with a significant increase in treatment related toxicity and time to tumour progression (Prado, 
Baracos, McCargar, Reiman, Mourtzakis, Tonkin, Mackey, Koski, Pituskin & Sawyer 2009).   
 
There are three phases of cachexia, namely precachexia, cachexia and refractory cachexia.  Patients 
with precachexia may experience some symptoms of cachexia, such as anorexia, without 
demonstrating significant unintentional weight loss.  Patients are considered to be cachectic when 
they demonstrate involuntary weight loss of more than 5% over a six month period, or experience 
persistent weight loss of more than 2% with a BMI of less than 20 kg/m2.  Patients classified as 
experiencing refractory cachexia are often in an extremely catabolic state.  Their cancer often 
progresses at a rapid rate and is less responsive to therapy.  In such situations, palliative 
management of patients is often more appropriate and, in many situations, the benefit of artificially 
feeding patients is often not justified when weighed against the potential risks and discomfort 
associated therewith.  Instead of trying to reverse muscle and weight loss, interventions for these 
patients are rather aimed at alleviating acute symptoms and distress (Fearon et al 2011).   
 
The severity of cachexia can be related to the degree of hypercatabolism that a patient experiences.  
Although inflammation is thought to be a cause of cachexia, it can sometimes occur in the absence 
of obvious systemic inflammation, therefore the measurement of indices such as C-reactive protein 
cannot be solely relied upon to classify severity.  Tumour metabolism can further drive catabolism 
(Fearon et al 2011).   
  
The assessment of muscle strength and mass is useful when assessing cachectic severity.  There is 
no set standard for how best to measure such factors, and some tests such as magnetic resonance 
imaging (MRI) and dual-energy X-ray absorptiometry (DXA) imaging are simply not available or 
accessible to many patients.  Arm muscle area and hand grip dynamometry, on the other hand, are 
often more practical tools for assessing muscle strength and mass in cancer patients.  Analysis of 
physical functioning and a patient's psychosocial status can also be useful when assessing cachexia 
severity.  Various tests and questions can be utilised to assess these, including analysing a patient's 
perceived quality of life, as well as determining how they feel regarding their reduced food intake 







2.3.4. Relationship between nutritional status on admission and survival 
It is evident that malnutrition, which develops due to a combination of factors mentioned above, can 
have a significant impact on children with cancer.  Opinions regarding the strength of utilising 
nutritional status on admission as a prognostic indicator are conflicting (Rogers 2014).  
Furthermore, there is a paucity of data assessing this relationship, particularly when it comes to 
children with solid tumours (Rogers & Ladas 2011).   
 
A large proportion of the research analysing this relationship has been conducted on children with 
haematological malignancies.  A study conducted by Hoffmeister et al (2013) on children who 
underwent an hematopoietic cell transplant showed a significant relationship between arm muscle 
area and both short- and long-term event free survival (100 days and three years post-transplant, 
respectively).  A large trial with 1787 children with cancer (solid tumours and haematological 
malignancies) was conducted by Sala et al (2012).  The study demonstrated a significant link 
between malnutrition at diagnosis and increased mortality rates amongst children with solid 
tumours, including Wilms' Tumour.  This relationship was not significant for children with 
haematological malignancies.  When assessing children with solid tumours at two years post-
diagnosis, 26% of children who were severely malnourished at diagnosis were alive with no adverse 
events, compared to 59% of those who were adequately malnourished at diagnosis.  This was 
compared to 58% and 72%, respectively amongst children with haematological malignancies.  
Other studies, albeit on much smaller sample sizes, support the prognostic significance of 
malnutrition at diagnosis (Mejia-Arangure et al 1999; Viana et al 1994).  Malnutrition has also been 
linked to increased risk of relapse (Viana et al 1994), infections and toxicity (Orgel et al 2014). 
 
In contrast to this, studies have also shown a lack of evidence for a relationship between 
malnutrition and outcome.  A large study of 1025 children concluded that nutritional status at 
diagnosis should not be considered to be a strong indicator of prognosis amongst children with 
haematological malignancies (Weir et al 1998).  This evidence has been supported by further 
studies (Pedrosa et al 2000) including research conducted on South African children with Wilms' 
Tumour (Wessels et al 1999).  The significance of this relationship will unfortunately remain 
inconclusive until more studies are conducted.  After a comprehensive review of the literature, only 
four studies assessing the relationship between nutritional status on admission and outcome 
amongst children with cancer, with specific focus on solid tumours, were found.  These studies are 






Table 2.2: Studies assessing the relationship between nutritional status at diagnosis and outcome amongst children with solid tumours 
Study Objectives Subjects Methods Results Limitations Conclusion 
Effect of malnutrition 
at the time of 
diagnosis on the 
survival of children 
treated for cancer in 
El Salvador and 
Northern Brazil 
 
Pedrosa et al (2000) 
 
Location:  El Salvador 
and Brazil 





survival.   
443 children  
 HM = 283   











 WFA = 
23.5% 
 HFA = 22.8% 


















looking at ST 
group 
separately.   
No significant relationship 
between nutritional status 
at diagnosis and outcome.   
 
Nutrition, morbidity, 
and survival in South 
African children with 
Wilms' Tumor. 
 
Wessels et al (1999) 
 
Location:  South 
Africa 
To determine the 
effect of nutritional 
status at diagnosis 
on the morbidity of 
treatment and 
outcome. 
















survival rates for 
normal vs. 
malnourished 
children = 56% 
vs. 74% 
 







Malnutrition at diagnosis 
not related to poorer 







Study Objectives Subjects Methods Results Limitations Conclusion 
Does body mass index 
at diagnosis or weight 
change during therapy 




A report from the 
Children's Oncology 
Group Soft Tissue 
Sarcoma Committee. 
 
Burke et al (2013) 
 
Location:  United 
States of America 
To determine the 
effect of weight loss 
during therapy on 




468 children with 
Rhabdomyosarcoma 





 Weight  
 Height 
















and length of 
hospital stay. 




Nutritional status on 
admission was not 
significantly related to 
survival. 
 










Study Objectives Subjects Methods Results Limitations Conclusion 
Nutritional status at 
diagnosis is related to 
clinical outcomes in 
children and 
adolescents with 
cancer:  A perspective 
from Central America 
 
Sala et al (2012) 
 






To assess nutritional 
status at diagnosis. 
 
To correlate 




relapse and death). 
1787 children  
1-18 years old 
(of whom 1513 had 




HM = 1143 
















 BMI = 28%  










59.2% severe  
 Type of 
cancer: 
ST = 56% 
Leukaemias 
(other than 
ALL) = 69% 
 













HM vs. ST 
groups. 
There was a high 
prevalence of malnutrition 
amongst children with 
cancer in developing 
countries. 
 
AA was a sensitive 
measure of nutritional 
status amongst children 
with cancer.  
 
Malnutrition was 
significantly related to 
higher mortality rates 
amongst children with ST.  




significantly related to 
frequency of treatment 
abandonment amongst ST 







Study Objectives Subjects Methods Results Limitations Conclusion 
depleted =  
48% 
 
EFS two years 
post diagnosis - 
ST vs. HM: 
 Severely 
depleted = 
26 vs. 58% 
 Well-
nourished = 







AA Arm Anthropometry HM Haematological Tumours 
ALL Acute Lymphoblastic Leukaemia MUAC Mid Upper Arm Circumference 
AMA Arm Muscle Area ST  Solid Tumours 
AMC  Arm Muscle Circumference TSFT  Triceps Skinfold Thickness 
BMI  Body Mass Index WFA  Weight for Age 
EFS  Event Free Survival WFH  Weight for Height 






2.3.5. Weight loss during cancer treatment 
Many recent studies have changed the focus of interest and, instead of only assessing nutritional 
status at the time of admission; have gone one step further by assessing weight changes during the 
course of cancer treatment.  Several studies have demonstrated that progressive weight loss during 
therapy is common amongst children with cancer (Brinksma, Roodbol, Sulkers, Kamps, de Bont, 
Boot, Burgerhof, Tamminga & Tissing 2015; Orgel et al 2014; Antillon et al 2013; Burke et al  
2013; Zimmermann, Ammann, Kuehni, De Geest & Cignacco 2013).  Zimmermann et al (2013) 
conducted a study which monitored changes in BMI during treatment.  The results showed a steady 
increase in the prevalence of malnutrition from 5.8% at baseline to 36% after 60 days and 47% by 
the end of the treatment period.  These findings were supported by Burke et al (2013) who found 
that, after six months of treatment, 18.2% and 18.7% of patients lost more than 5% and 10% of their 
baseline weight, respectively.  Antillon et al (2013) suggested that nutritional status at six months 
after the commencement of treatment is a more accurate indicator of survival compared to 
nutritional status on admission.  Children who were well-nourished or moderately malnourished at 
this stage of treatment had a significantly more favourable chance of surviving than those who were 
classified as severely malnourished (Antillon et al 2013).   
 
Orgel et al (2014) took this a step further by assessing the influence of weight extremes during 
treatment on event free survival as well as treatment-related toxicity.  In their large sample of over 
2000 children, they found that children who were underweight for more than 50% of the time 
during the induction and intensive (pre-maintenance) phases of treatment had significantly poorer 
survival compared to those who were underweight for shorter periods of time during treatment.  
Children who presented in an undernourished state on admission and remained underweight for 
more than 50% of the pre-maintenance treatment period were almost twice as likely to relapse or 
die compared to those who were adequately nourished during treatment.  Of significance was the 
finding that children who presented as underweight but who gained weight and were subsequently 
classified as well-nourished during the treatment period had a much lower risk of relapse, toxicity 
or death.  Their risk thereof was comparable to those who presented in a well-nourished state.  This 







2.3.6. The role of nutritional intervention 
Unlike many unmodifiable risk factors for cancer, such as age and gender, nutritional status can be 
changed or altered if nutritional interventions are implemented (Orgel et al 2014).  Nutritional 
intervention amongst children with cancer should aim to meet the patient's needs, both nutritional 
and psychosocial, on an individualised basis.  Furthermore, the type of intervention should be 
appropriate for the specific patient's situation and if the gut is working it should be utilised 
whenever possible (Van Eys 1998).  However, according to a survey of 125 institutions treating 
children with cancer worldwide, nutrition related practices (such as time of assessment and criteria 
used, estimation of nutritional requirements and timing, type and route of nutritional intervention) 
were shown to be erratic and inconsistent.  More than half of these institutions did not conduct 
nutritional assessments at diagnosis, while a variety of criteria were used in order to determine if 
and when nutritional interventions were implemented (Ladas et al 2006).   
 
Several studies have shown the benefits and effectiveness of nutritional intervention (De Waele, 
Mattens, Honore, Spapen, De Greve & Pen 2015; Sacks, Hwang, Lange, Tan, Sandler, Rogers, 
Womer, Pietsch & Rheingold 2014; Antillon et al 2013; Barbosa, Pedrosa & Cabral 2012).  The 
efficacy of nutritional intervention amongst children with Wilms' Tumour in particular has also 
been demonstrated by Holzinger et al (2007).  The authors showed that provision of 
supplementation, in the form of oral nutritional supplements and/or enteral feeding, led to 
significant weight gain in the majority of patients. 
 
As described in the definition mentioned earlier, cachexia cannot be reversed or "cured" by 
conventional types of nutritional interventions (Fearon et al 2011).  Many cachectic patients are 
hypermetabolic, as demonstrated in the study conducted by Dev, Hui, Chisholm, Delgado-Guay, 
Dalal, Del Fabbro & Bruera (2015).  However, when compared to cachectic patients with normal 
metabolic rates, the two groups were shown to have a similar prognosis.  Furthermore, 
hypermetabolism was not shown to have a strong influence on velocity of weight loss or symptom 
burden.  This emphasises the importance of treating and addressing all potential nutrition-related 
symptoms of cachexia, including nausea, constipation and early satiety along with 
hypermetabolism, in order to prevent weight loss and facilitate weight gain amongst this population 
(Dev et al 2015). 
 
Although nutritional intervention and resuscitation amongst these patients is more challenging than 






(2015) conducted a study over a period of one year to assess the efficacy of nutritional intervention 
amongst cachexia patients, in the form of intensive personalised dietary programs and continued 
support from a dietitian and doctor.  Although this study had a small sample size, it showed that 
nutritional support was beneficial and important amongst the cachectic population.  The subjects 
who received dietary intervention were shown to have significantly shorter hospital stays compared 
to the control group (3.4 days versus 37.6 days), as well as significantly improved survival.  They 
also tended to show a better response to treatment and were shown to have a more stable body 
weight during the course of the study compared to the control group (De Waele et al 2015).   
 
In addition to this, the psychological aspects of cachexia, for both the patient and their family, need 
to be addressed.  Studies have shown that patients and their families show poor understanding of 
cachexia, including its causes and the symptoms associated therewith.  They often attributed 
continued weight loss to perceived absence of dietary interventions, which left them feeling 
hopeless and isolated and could be detrimental to the quality of life of patients and their family 
members (Reid, McKenna, Fitzsimons & McCance 2010).  The importance of multidisciplinary 
team (MDT) management of these patients, who are notoriously difficult to treat, should be 
emphasised (De Waele et al 2015). 
 
2.4. Conclusion 
Developing countries face many debilitating problems related to the treatment of children with 
cancer, which lead to increased treatment abandonment (Paintsil et al 2015; Madani et al 2006), 
rates of malnutrition (Sala et al 2012; Israels et al 2009; Israels et al 2008; Garofolo et al 2005) and 
poorer survival (Paintsil et al 2015; Abuidris et al 2008).  Many developing countries have failed to 
effectively collaborate in order to optimise the management and treatment of children with cancer 
(Ekenze et al 2006).  MDT management is important (Barbosa et al 2012; Ekenze et al 2006) and 
has proven to be effective amongst cancer patients in particular (De Waele et al 2015).  It is 
important to establish sensitive methods whereby the nutritional status of children with cancer can 
be accurately classified and those at high risk of becoming malnourished can be identified early 
(Elhasid et al 1999).  Furthermore, these methods need to be standardised amongst all institutions 
treating children with cancer in order to gain an understanding of the true prevalence of 
malnutrition amongst this population.   
 
There is a paucity of research focusing on Wilms' Tumour in general, and particularly in a South 






challenges that are present in a resource limited setting, it is important to understand how 
modifiable factors, such as nutritional status, influence disease outcome, and how nutritional 
intervention can be used most effectively in order to improve outcome.  This will guide health care 
providers and policy makers in the right direction in order to provide the most efficacious treatment 
for this population, including developing guidelines relating to the most effective nutritional 
management.  This study, which had a sample incorporating two provinces in South Africa, aimed 
to provide an accurate prevalence of malnutrition on admission amongst Wilms' Tumour patients.  
Furthermore, it aimed to determine the influence of malnutrition at the time of admission on 
outcome after two years, as well as the level of nutritional support provided to children with Wilms' 







CHAPTER 3: METHODOLOGY 
 
In this chapter the following sections relating to the methodology used in this study are discussed:  
the literature relating to the particular research methodology utilised, the population and sample 
selection, statistical analysis of the data as well as ethical considerations of the study. 
 
3.1. Type of study 
This prospective observational study utilised a cohort study design in order to assess the prevalence 
of malnutrition amongst children with Wilms' Tumour at IALCH between 2004 and 2012.   
 
3.2. Background information on study site 
IALCH is classified as a National Central Hospital and services a large catchment area spanning 
two of South Africa's seven provinces, including all districts in KZN and the seaboard area of the 
Eastern Cape.  It is a referral hospital for all tertiary and district hospitals in the KZN province 
(Department of Health 2014) (Figures 3.1 and 3.2) and has a catchment area of over ten million 
people (Stats SA 2011).  Furthermore, it also accepts referrals from the seaboard area of the Eastern 
Cape, and other parts of the country on occasion.  According to the most recent census data, almost 
45% of households in KZN are situated in rural areas.  Black Africans make up the vast majority of 
the population in KZN (86.8%), followed by the Indian/Asian (7.4%) White (4.2%) and Coloured 
(1.4%) population groups (Stats SA 2011).  In the Eastern Cape, Black Africans make up 86.3% of 
the population, followed by Coloureds (8.3%), Whites (4.7%) and Indians/Asians (0.4%).  
Therefore, although this is a single centre study, the study population is reflective of the 
demographics of the entire province (and South Africa as a whole) due to its unusually large 
catchment area.  Table 3.1 provides demographic information regarding education and income of 
the different ethnic groups in South Africa.  Furthermore, it provides information regarding the use 













Table 3.1: Demographic information for different ethnic groups in SA (Stats SA 2011) 
 Black Coloured White Indian/Asian 
Education – No school (%) 10.5 4.2 0.6 2.9 
Education – Gr 12 (%) 27.1 25.4 40.8 40.4 
Income (R/annum) 60 613 112 172 365 134 251 541 
Utilisation of public health care (%) 87.84 8.55 2.32 1.55 
 
Data was collected by the dietitians who were working in the paediatric surgical ward at IALCH 
between 2004 and 2012.  This data was initially collected to be utilised in a broader study, however, 
it was subsequently utilised in two separate studies.  The first study focused on the influence of 
nutritional status on the outcome of subjects, while the second focused on the influence of 





















3.3. Study design 
3.3.1. Prospective observational studies 
Observational studies employ a study design by which the investigator merely observes the study 
population without implementing any type of intervention (Mann 2003).  The prevailing opinion 
that results obtained from observational trials are inferior to those of randomised controlled trials 
has been challenged.  In contrast to this belief, it has been shown that observational studies that 
have been rigorously designed and well conducted can provide results of a similarly high standard 
to those obtained from randomised controlled trials (Concato, Shah & Horwitz 2000).   
 
A prospective observational study is defined as "an observational study, often longitudinal in 
nature, for which the consequential outcomes occur after study commencement" (Berger, Dreyer, 
Anderson, Towse, Sedrakyan & Normand 2012).  In other words, this study design implies that the 
group of people selected for the study do not display the outcome of interest at the time of initial 
selection.  This allows the researcher to identify one or more potential variables that may influence 
the outcome, and collect the relevant data related to these variables.  At the end of the research 
period, the researcher is then able to analyse the data to determine which (if any) variables 
influenced whether or not the outcome did in fact occur (Mann 2003).  In this study, the outcome of 
interest refers to whether or not the subject was alive at two years after their initial admission and 
diagnosis.   
 
Conversely, retrospective studies involve looking back at information that has already been 
gathered (Berger et al 2012), sometimes for completely different purposes (Mann 2003).  These 
data are analysed after the exposures and outcomes have already occurred (Berger et al 2012).  
From this information, the investigator attempts to ascertain if there is a link between variables 






Table 3.2: The advantages and disadvantages of prospective versus retrospective studies  
  (Berger et al 2012; Euser, Zoccali, Jager & Dekker 2009; Mann 2003). 
 Advantages Disadvantages 
Prospective  Possibility of collecting 
additional information relating 
to outcome/exposure 
 Improved accuracy of data 
collected (as variables are 
identified before the study 
commences) 
 Time consuming 
 Expensive 
 Potential loss of efficiency due 
to prolonged study period 
 Subjects lost to follow up 
 Vulnerable to confounding 
variables 
Retrospective  Time-efficient 
 Allows for researchers to 
answer new questions without 
having to collect new data 
 Cheaper to conduct 
 Incomplete data sets 
 Definition of exposure and 
outcome may be difficult 
 Data often collected for a 
different purpose 
 
3.3.2. Cohort studies 
Cohort studies are considered to be an effective study design to determine objectives such as 
incidence, cause (Mann 2003) and prognosis (Thadhani & Tonelli 2006; Mann 2003).  The major 
aim of cohort studies is to compare groups, either exposed or unexposed to a certain variable, in 
order to determine their risk of experiencing a single or multiple outcomes.  Prospective cohort 
studies are considered to be the most effective type of observational study when analysing this 
particular relationship (Thadhani & Tonelli 2006).  At the end of the study, the number of subjects 
who experience the specific outcome are assessed in relation to whether they were exposed or 
unexposed at baseline (Euser et al 2009).  The data are usually analysed in order to determine the 
relative risk ratio, which is defined as "the ratio of the probability of developing the condition if 
exposed to a certain variable compared with the probability if not exposed" (Mann 2003).   
 
A significant advantage of prospective cohort studies is that they minimise the debate regarding 
what is the cause and what is the effect, as the outcome had not yet occurred at the time of initiating 
the trial (Mann 2003).  Furthermore, more than one hypothesis can be tested, and several possible 
effects of a particular exposure can be assessed, when utilising this study design (Euser et al 2009; 
Thadhani & Tonelli 2006).  Results from these studies can be further generalised to wider 
populations (Euser et al 2009).  Unfortunately cohort studies may not allow the researcher to 







3.4. Study population and sample  
Between 2004 and 2012, the period during which this study was conducted, IALCH was home to 
the only state-run specialised paediatric oncology unit treating children with Wilms' Tumour in the 
KwaZulu-Natal (KZN) province.  Therefore, all children in KZN suspected of having Wilms' 
Tumour were referred to IALCH for diagnosis and treatment.   
 
The study population included 88 children between the ages of 6 months and 13 years who were 
admitted to the paediatric surgery ward at IALCH between 2004 and 2012 and diagnosed with 
Wilms' Tumour.  Two of these children were excluded as their anthropometric data was collected 
after the initiation of nutritional intervention and/or chemotherapy.  A further ten children were 
excluded as their full medical files could not be located, which led to incomplete data.  The final 
sample consisted of 76 children whose data were analysed. 
 
3.5. Study methods and materials 
This section outlines the different methods utilised to assess nutritional status, and focuses on the 
rationale behind the criteria that were chosen to classify overall nutritional status. 
     
3.5.1. Anthropometry 
Between 2004 and 2012, subjects were assessed by the ward dietitian after admission to the 
paediatric surgical ward.  Their anthropometric measurements took place before the initiation of any 
interventions in the form of nutritional supplementation or chemo/radio-therapy.  This data was 
recorded in a Microsoft Excel spreadsheet on the IALCH Dietetics department's server in order to 
be utilised for this study. 
 
Anthropometric status was assessed using weight, height, MUAC and TSFT measurements.  Body 
weight and height were measured using a Nagata electronic weight and height measurement scale 
(Model BW-1122H).  Infants were weighed on a Nagata electronic baby scale (Model BW-20) and 
their length measured with a measuring tape (supine position).  Weight was recorded to the nearest 
100g and height and length to the nearest 1cm.  Subjects wore light clothing and no shoes when 
measurements were taken.  Height measurements were taken while subjects stood up straight on the 
electronic scale with their back against the height-meter, looking straight ahead.  These scales are 






weight was recorded by the paediatric surgeon post-operatively and the corrected weight was 
utilised for statistical analysis in order to give a more accurate reflection of nutritional status on 
admission. 
 
In order to measure MUAC, the midpoint between the acromion process of the scapula and 
olecranon process of the ulna was determined while the left forearm was bent at a right angle.  A 
non-stretchable measuring tape was then used to measure the circumference at the midpoint while 
the arm hung straight down, to the nearest 0.1cm.  TSFT was measured on the same midpoint using 
a Harpenden skinfold caliper and recorded to the nearest 0.1cm.  Both measures were performed in 
triplicate and the average recorded in order to ensure accuracy. 
 
Weight and height measurements were utilised to determine weight for age (WFA), length for age 
(LFA)/height for age (HFA), weight for height (WFH)/weight for length (WFL) and BMI 
depending on the age of the subject.  These were classified according to age and gender matched 
norms utilising the STAT GrowthCharts app (Austin Physician Productivity, LLC 2012), which 
classifies subjects according to Z-scores using the WHO growth charts.  These WHO growth charts 
were developed based on data collected from children of different ethnic backgrounds, from six 
diverse geographical areas during the WHO Multicentre Growth Reference Study.  MUAC and 
TSFT measurements were compared with age and gender matched norms and interpreted using the 
Frisancho percentile charts (Frisancho 1981).  Although the Frisancho charts were based on a 
sample of only white people, they were the only charts that allowed classification of MUAC and 
TSFT based on the same sample.  Furthermore, several related studies used the Frisancho charts in 
order to classify nutritional status of their samples (Murphy et al 2009; Israels et al 2008; Tazi et al 
2008; Garofolo et al 2005).  Therefore, use of the same charts in this study allowed for more direct 
comparison of the results of this study to these previous studies. 
3.5.2. Biochemistry  
Albumin levels were routinely assessed on admission to hospital, and albumin was considered to be 
low if levels were below 35g/L (Heber et al 2010).  Albumin levels were tested in the laboratory at 
IALCH using Bromocresol Green (BCG).  BCG is a compound that has been shown to bind to 
human serum albumin.  Upon interaction with serum albumin the fluorescent characteristic of the 
BCG changes, turning it bright green.  The intensity of the fluorescence gives an indication of the 
quantity of albumin present in the sample being tested (Trivedi, Saxena, Siddiqui & Qasim 1997). 






3.5.3. Classification of nutritional status 
In order to classify subjects as malnourished or well-nourished, a combination of arm 
anthropometry and albumin were used.  These variables were selected based on an analysis of 
variables utilised by a variety of studies measuring nutritional status in the past (Table 3.3), as well 
as recommendations regarding classification of nutritional status amongst children with cancer from 
recent literature (Sala, Antillon, Pencharz, Barr & AHOPCA Consortium 2005). 
 
Table 3.3:  Variables used to classify nutritional status in previous studies 
Author  Wt 
Corr 
wt Ht WFA HFA WFH BMI MUAC TSFT Alb 






X X  
Elhasid et al 1999 X 
        
X 
Pedrosa et al 2000 X 
 
X X X X 
   
 
Pietsch & Ford 2000 X 
 
X X X X X 
  
X 




X X X X  
Holzinger et al 2007 X 
 
X 
      
 
Israels et al 2008 X 
 
X X X X 
 
X X  
Tazi et al 2008 X 
 
X X X X X X X X 




X X  
Murphy et al 2009 X 
 
X 
   
X X X X 
Burke et al 2013 X 
 
X 




Wt - Weight, Corr wt - Corrected weight, Ht - Height, Alb - Albumin 
 
Table 3.3 shows that there was no standard protocol being utilised by researchers in order to 
classify nutritional status amongst children with cancer.  Due to the improved sensitivity and 
accuracy of arm anthropometry when assessing nutritional status amongst this population (Lemos et 
al 2014; Israels et al 2008; Tazi et al 2008; Garofolo et al 2005), and children with solid tumours in 
particular (Sala et al 2012; Tah et al 2012; et al 1999), this study utilised MUAC and TSFT 
measurements as part of the criteria to classify nutritional status.  Albumin was also included 
alongside arm anthropometry in order to improve sensitivity (Sala et al 2012).  Measurements 
utilising weight and height were not included in this classification system due to the evidence that 
these parameters often grossly underestimate the prevalence of malnutrition amongst children with 
cancer (Lemos et al 2014; Israels et al 2008; Tazi et al 2008; Garofolo et al 2005).  Over and above 
this, nutritional status was classified utilising variables in isolation (MUAC and TSF, albumin, 






In order to classify overall nutritional status in this study, a combination of anthropometry and 
biochemistry was used.  Subjects who met at least one of these criteria were classified as 
malnourished:  
 MUAC and TSFT between the fifth and tenth percentiles 
 MUAC less than the fifth percentile and TSFT more than the tenth percentile 
 MUAC more than the tenth percentile and TSFT less than the fifth percentile 
 Albumin less than 35g/L 
Those with a MUAC and/or TSFT below the 10th centile, or albumin levels below 32g/L, were 
classified as being severely malnourished. 
 
This combination of criteria, which have been modified and utilised in previous studies (Antillon et 
al 2013; Tazi et al 2008), was adapted from the guidelines developed at the AHOPCA congress in 
2005 (Sala et al 2005).  
 
3.5.4. Level of nutritional support  
Any nutritional support that subjects received was recorded in their electronic files by the dietitian 
at the time of intervention.  Early intervention was considered to be any dietary intervention that 
took place within two weeks of admission, before the commencement of treatment.  Data relating to 
the type of assessment and the type of nutritional intervention (oral, enteral or parenteral) were 
documented for analysis. 
 
3.6. Data analysis 
Anthropometric measurements were recorded on a Microsoft Excel spreadsheet which was only 
accessible to the Dietetics Department at IALCH in order to ensure confidentiality.  Outcome data 
was obtained by the researcher using electronic patient records and would have been recorded by 
the doctor.  Once the data had been collected it was entered onto a Microsoft Excel spreadsheet on 
two separate occasions. After this the two data sets were given to an independent party for 
comparison in order to detect any discrepancies.  The data was then analysed using the Statistical 
Package for Social Sciences (SPSS) version 21.  Descriptive tests as well as the Chi-Squared test of 
independence were carried out in order to analyse the data.  For this study, a p value of less than 
0.05 was considered to be significant.  Table 3.4 provides details regarding each objective, the 






Table 3.4:  Data analysis of objectives 
Objectives Variables Method of analysis 
To determine the prevalence of malnutrition 
using a combination of anthropometric and 










To determine the influence of nutritional 
status on the outcome of children with Wilms' 
Tumour.  




 Alive or dead 
Chi-square test of 
independence  
Significance below 0.05 
To determine the level of nutritional support 






3.6.1. Reliability and validity 
If the reliability and validity of a measurement is not known, one would not be able to determine if 
the results of a study utilising that measurement are accurate.  Validity refers to "whether a study is 
able to accurately answer the questions it was intended to answer".  In order for a study to be valid, 
the measurements of outcomes need to provide a true reflection of the situation that is being 
analysed or assessed.  Validity of a study can be further broken down into internal validity (how 
accurately a measurement reflects what it was intended to reflect) and external validity (how well 
the study information can be generalised to other populations) (Berger et al 2012). 
 
According to Sapp & Jensen (1997), "the goal of scientific measurement is to develop instruments 
with a minimum of systematic error that are sufficiently precise so as to minimize chance errors 
during the measurement process".  Although repeated measurements of the same variable may 
never be identical, if measurements are conducted correctly then it can be expected that the results 
would be consistently similar.  Reliability refers to the trustworthiness of the measurement tools 
used in a study and is defined as “the extent to which an experiment, test, or any measuring 
procedure yields the same results on repeated trials” (Carmines & Zeller 1979, p11).  Over the 
course of this study, the same procedures and steps were followed when taking all anthropometric 
measurements.  This was in line with the standard protocols used to take anthropometric 
measurements as determined by the IALCH Dietetics Department.  Measurements for TSFT, in 






may have occurred when taking skinfold measurements.  Furthermore, biochemistry tests were 
conducted as per the policies and procedures specified in the pathology laboratories.  
 
3.7. Reduction of bias 
Bias refers to a situation when "results of a study systematically deviate from the truth because of 
non-random factors".  Selection bias, information bias and confounders are considered to be the 
main categories of bias (Thadhani & Tonelli 2006).  Bias can occur before, during and after a trial, 
and should be given due consideration at all stages (Pannucci & Wilkins 2010).  In this study, the 
main concerns regarding bias were inter-observer bias, transfer (loss to follow up) bias, 
confounding variables and selection bias.  These are discussed next.   
 
3.7.1. Inter-observer bias 
With regards to anthropometric measurements, non-random errors are a potential source of bias and 
can occur if the equipment utilised in the study produces inaccurate measurements (Carmines & 
Zeller 1979, p14).  The electronic scales utilised in this study were calibrated annually, therefore 
reducing the risk of this type of bias.  More than one dietitian worked in the paediatric surgical ward 
over the time period during which data was gathered.  This may have introduced the risk of inter-
observer bias, as the dietitians may have used different techniques when taking anthropometric 
measurements, which could have affected the reliability of the results.  However, according to 
Pannucci & Wilkins (2010), this type of bias can be minimised by having standardised protocols 
relating to the collection of data.  In the Dietetics Department at IALCH, measurement of 
anthropometric indices as part of the process of classifying nutritional status is standardised 
throughout the department and all dietitians follow the same standardised steps when taking weight, 
height, MUAC and TSFT measurements for all patients.  Therefore it was assumed that all 
measurements for this study were taken consistently and accurately.  Furthermore, when data was 
collated during the study period, no changes in coding or parameters occurred throughout the 
duration of compilation of the database, thereby limiting the risk of inaccuracies. 
 
3.7.2. Transfer bias 
Transfer bias can occur due to high rates of loss to follow up.  This type of bias can affect the 






numbers of subjects from each group are lost to follow up (Pannucci & Wilkins 2010).  In this 
current study loss to follow up rates were low, with only eight subjects not following up for the full 
two year period.  Of these eight subjects, all but two completed their treatment regimens. 
 
3.7.3. Confounding variables 
Confounding variables are those that can have a direct and independent influence on both the 
exposure and outcome being analysed.  All variables that could potentially have an influence should 
be analysed in order to ensure all eventual confounding variables are accounted for (Mann 2003).  
Stage and histology are considered to be the strongest prognostic indicators amongst children with 
cancer (Kaste et al 2008).  In this study, stage and histology were considered to be confounding 
variables and the influence of this on outcome was addressed by means of a regression analysis. 
 
3.7.4. Selection bias 
Subject selection bias refers to selecting a cohort that does not represent the broader population of 
subjects who could potentially develop the outcome in question (Thadhani & Tonelli 2006).  
Although this was a single-centre study, this type of bias was minimised due to the large catchment 
area of IALCH, which services over ten million people. 
 
3.8. Ethical considerations 
Ethical clearance was obtained from the Biomedical Research Ethics Committee of the University 
of KwaZulu-Natal (Reference: BE025/13) (Appendix A).  In addition to this, approval was obtained 
from the Medical Manager at IALCH (Appendix B) as well as the KZN Department of Health 
Research Committee (Reference: HRKM 227/13) (Appendix C) to conduct this study.  Individual 
consent was not required as data was obtained by the ward dietitian as part of the nutritional 
assessment of each patient on admission.  In order to ensure the confidentiality and anonymity of 
each participant, data was coded when added to the database.  Subjects were not identified in the 
study as no names or surnames were revealed. 
  
3.9. Summary 
This chapter discussed the methods utilised to classify nutritional status in order to determine the 






chosen as part of the criteria to determine nutritional status, including analysis of available literature 
relating to this topic.  It focused on the steps taken in order to ensure that the results produced by 
this study would be valid and reliable.  Furthermore, it detailed how bias was addressed at all stages 
of the study in order to ensure the results were as accurate as possible.  The next chapter discusses 






CHAPTER 4: RESULTS 
 
This chapter presents the results of the study.  The characteristics of the sample are presented in 
order to facilitate a better understanding of the population in question.  Furthermore, the results of 
the data analyses are assessed in order to describe the true prevalence of malnutrition amongst this 
population, as well as the relationship between nutritional status and outcome. 
 
4.1. Sample characteristics 
The study sample consisted of 76 children with Wilms' Tumour.  Half of the sample (50%; n = 38) 
was made up of males, and the other half females (50%; n = 38).  The majority of the sample 
consisted of Black African children (97.3%; n = 74), while 2.6% (n = 2) comprised White and 
Coloured children.  The mean age of the subjects was four years and eight months (SD ± 2.89), and 
the median age was three years and ten months (IQR = 37.32 months).  The anthropometric and 
demographic characteristics of the sample are presented in Table 4.1.  Median height for males and 
females was 0.98 (IQR = 0.23) metres, while females on average weighed slightly more than males 
(16.99kg versus 16.56kg).  Consequently, the mean BMI for females [16.17kg/m2 (SD ± 2.69)] was 
slightly higher than that of males [15.30kg/m2 (SD ± 1.83)].  The mean albumin level amongst the 
sample was 38.61g/L (SD ± 5.87). 
 
Table 4.1:  Anthropometric and demographic characteristics of the study population 
 Mean Median IQR Min Max SD 
Age (months) 
Combined (n = 76)  
Males (n = 38) 


























Combined (n = 76) 
Males (n = 38) 


























Combined (n = 75) 
Males (n = 37*) 


























Combined (n = 75) 
Males (n = 37*) 

































Details relating to the distribution of disease stage by gender are shown in Table 4.2.  Most of the 
patients presented in stages three to five (71%; n = 54), while just over one quarter of the study 
sample presented in stage one or two (29%; n = 22). 
 
Table 4.12:  Distribution of disease stage by gender 
 Stage 1 
(n = 6) 
Stage 2 
(n = 16) 
Stage 3 
(n = 19) 
Stage 4 
(n = 29) 
Stage 5 
(n = 6) 
Male, n, (%) 3 (50) 8 (50) 11 (58) 12 (41) 4 (67) 
Female, n, (%) 3 (50) 8 (50) 8 (42) 17 (59) 2 (33) 
 
Table 4.3 shows the distribution of disease stage by the age of the subjects.  The mean age was the 
lowest for those in stage one.  The majority of the subjects presented in stage four, with the highest 
mean age of 5.68 years.     
 
Table 4.3: Distribution of disease stage by age 
Stage Count Max Age Min Age Mean Age SD 
1 6 3.5 0.92 1.93 0.85 
2 16 11.58 1.17 4.65 3.17 
3 19 12.42 1.83 4.35 2.60 
4 29 12.25 1.5 5.68 3.05 
5 6 4.25 2.5 3.32 0.62 
 
4.1.1. Prevalence of malnutrition on admission 
Table 4.4 shows the prevalence of malnutrition according to various anthropometric measurements 
that are commonly utilised to classify nutritional status.  According to WFA, HFA and BMI results, 
most of the sample was classified as well-nourished.  However, according to arm anthropometry 
measurements, the prevalence of malnutrition was much higher.  Of particular concern is the fact 
that the prevalence of severe malnutrition remained below 6% when arm anthropometry was not 








Table 4.4:  Anthropometric classification of study population 
 Female Male Combined 
n % n  % n % Total % 
WFA (n = 71*) 
Normal  
Underweight, mild (<-1 SD) 
Underweight, moderate (<-2 SD) 



































HFA (n = 75**) 
Normal  
Underweight, mild (<-1 SD) 
Underweight, moderate (<-2 SD) 



































BMI (n = 75**) 
Normal  
Underweight, mild (<-1 SD) 
Underweight, moderate (<-2 SD) 



































MUAC (n = 74#) 
Normal  
Underweight, mild (<-1 SD) 
Underweight, moderate (<-2 SD) 



































TSFT (n = 71##) 
Normal  
Underweight, mild (<-1 SD) 
Underweight, moderate (<-2 SD) 




































*  Five subjects could not be classified due to insufficient age specific growth charts – WHO WFH growth charts not 
available for children over the age of ten years. 
** Height information not available for one subject  
#  MUAC not available for two subjects 
##  TSFT not available for five subjects 
NW – Normal Weight; UW – Underweight 
 
Figure 4.4 shows a comparison between different combinations of measurements when classifying 
nutritional status.  When albumin was utilised to classify nutritional status in isolation, 70% (n = 
53) of subjects were classified as being well-nourished.  In this study, a combination of MUAC, 
TSFT and albumin was used to classify overall nutritional status.  Interestingly, when looking at 
these three indicators combined, eight subjects were classified as being malnourished based on their 
albumin levels alone (in other words, their arm anthropometry measurements were normal but their 
albumin levels were low).  The results showed that two thirds (n = 47; 66.67%) of the sample (n = 








Figure 4.1: Prevalence of malnutrition using biochemical and anthropometric measurements 
 
4.2. Influence of stage of disease and tumour burden on nutritional status 
In this section, the influence of stage of disease and tumour burden on nutritional status is assessed. 
 
4.2.1. Stage of disease and nutritional status 
The influence of stage of disease on nutritional status was analysed using the Fisher‟s exact test.  
Although it was difficult to make conclusions about the relationship between these two variables 
due to the small sample sizes in each group, this analysis showed a trend towards increased 
prevalence of malnutrition amongst those in stages two to four (Table 4.5).  Those in stage five had 
a lower prevalence of malnutrition compared to stages two to four.  Overall, the influence of stage 













































(n = 5) 
Stage 2 
(n = 13) 
Stage 3 
(n = 19) 
Stage 4 
(n = 29) 
Stage 5 
(n = 6) 
Total 
(n = 72) 
p-value 
Yes, n, (%) 1 (20) 9 (69.23) 13 (68.42) 22 (75.86) 3 (50) 48 (66.67)  
p=0.152 No, n (%) 4 (80) 4 (30.77) 6 (31.58) 7 (24.14) 3 (50) 24 (33.33) 
 
* Four subjects did not have TSFT therefore their overall nutritional status could not be classified 
 
4.2.2. Tumour burden and nutritional status 
Figure 4.2 shows the tumour burden distribution amongst the sample.  Tumour burden is a 
reflection of the percentage of the subject's total body weight that consists of tumour mass.  Most of 
the subjects (86.5%; n = 64) had a tumour burden of less than 10%, while for almost 15% (n = 10) 
of subjects their tumour accounted for more than 10% of their total body weight.  In addition to this, 
the relationship between nutritional status and tumour burden was assessed using the Mann 
Whitney test.  Results showed that subjects who were malnourished did not have significantly 
larger tumour masses than those who were well-nourished (p = 0.339).  It should be noted that two 
children did not undergo surgery; therefore the weight of their tumours could not be determined.   
 
 




















4.3. Nutritional status and outcome 
The influence of nutritional status upon admission and outcome after two years is presented in 
Tables 4.6 and 4.7.  The overall nutritional status could not be classified for five subjects as their 
TSFT measurement was not recorded.  Outcome was defined as a subject being either dead or alive.  
It should be noted that the outcome of 14 of the subjects could not be described due to the following 
reasons: (i) eight subjects were lost to follow up (of those who were lost to follow up, only two 
failed to complete treatment); (ii) six subjects completed their treatment course (chemotherapy 
and/or radiotherapy and surgery) but did not return for their scheduled follow ups over the course of 
two years post initial admission.  The rate of treatment abandonment for this sample was 2.6%. 
   
Table 4.36: The association between malnutrition on admission and outcome; 2 years 
 Outcome  
Total Dead Alive 
n % n % n % 
Malnourished Yes 13 31.71 28 68.30 41 100.00 
No 4 19.05 17 80.95 21 100.00 
Total 17 27.42 45 72.58 62 100.00 
 
 
Of the 62 subjects, two thirds (n = 41) were classified as being malnourished on admission 
according to their MUAC, TSFT and albumin results.  Seventeen (27.42%) of the 62 subjects died 
during the two year follow up period.  Of the 17 subjects who died within the two year follow up 
period, 13 (76.47%) were malnourished on admission.  Of the 45 subjects who were alive within the 
two year follow up period, 28 (62.22%) were malnourished on admission.  No significant 
relationship between nutritional status on admission and outcome after two years was demonstrated 
utilising the Chi-squared test of independence (p = 0.443).   
 
It was also noted that no significant relationship was found between severity of malnutrition and 
outcome.  Table 4.7 shows that those who were well-nourished and those who were severely 












Table 4.37: The association between severity of malnutrition and outcome 
 Degree of malnutrition  
Total Normal Malnourished Severely 
malnourished 
n % n % n % n % 
Outcome Dead 4 25.00 6 37.50 6 37.50 16 100.00 
Alive 17 36.96 12 26.09 17 36.96 46 100.00 
Total  21 33.87 18 29.03 23 37.10 62 100.00 
 
Binary logistic regression analysis was conducted in order to account for confounding variables that 
are known to have a significant influence of prognosis (stage and histology).  No significant 
relationship between nutritional status and outcome was found, despite correcting for stage and 
histology (p = 0.711). 
 
4.4. Level of nutritional support received 
Most of the study sample (84.2%; n = 64) were provided with nutritional supplementation within 
two weeks of admission.  Just over 10% (n = 8) received supplements more than two weeks after 
admission and were therefore not included.  Only 5.3% (n = 4) of the sample did not receive any 
nutritional supplementation.  Of those who received nutritional supplementation, 87.5% (n = 56) 
received oral supplementation.  Oral supplementation refers to a nutritional supplement, a nutritious 
snack (for example yoghurt, full cream milk or a sandwich), or a combination of the two.  Of the 
remaining subjects, 9.4% (n = 6) received nasogastric (NG) feeds, whereas 3.1% (n = 2) received a 
combination of oral and NG supplementation.  There was no significant relationship between the 
severity of malnutrition and whether or not the subjects received supplements (p=0.768).  
Furthermore, there was no significant relationship between severity of malnutrition and type of 
nutritional support received (p=0.620). 
 
4.5. Summary of results 
The results of the statistical analyses assessing the prevalence of malnutrition and the influence of 








Of the total sample of 76 children with Wilms' Tumour, exactly half were male and half were 
female.  Black African children made up 97.3% of the sample, and the majority of the sample 
presented late (in stages three to five).  The mean age amongst the sample was 4.65 years, while 
67% of the sample was aged five years or younger. 
 
The prevalence of malnutrition was assessed using a variety of measurements.  When WFA, HFA 
and BMI were used to classify nutritional status, 35.3%, 38.7% and 29.4% of subjects were 
classified as being malnourished, respectively.  Of those who were classified as being malnourished 
utilising WFA, HFA or BMI, less than 6% were classified as being severely malnourished.  When 
arm anthropometry measurements were analysed, the prevalence of malnutrition increased 
substantially to 79.7% and 72% for MUAC and TSFT, respectively.  Similarly, the prevalence of 
severe malnutrition increased to 43.2% and 32.4% respectively.  Nutritional status was also 
classified using biochemistry by measuring albumin levels.  According to albumin levels, 70% of 
patients were well-nourished.  In order to classify the overall nutritional status, arm anthropometry 
measurements were utilised in combination with albumin.  According to this classification system, 
the overall prevalence of malnutrition amongst this sample was 67%.   
 
There was a trend towards an increased prevalence of malnutrition amongst subjects who presented 
in stages two to four, however, this was not found to be statistically significant.  When tumour 
burden was analysed, it was found to account for more than 10% of total body weight in almost 
15% of the subjects in this sample.  Subjects who were malnourished were not found to have 
significantly larger tumours compared to those who were well-nourished. 
 
During the two year follow up period, 27.4% of the sample had died.  Just over 76% of those who 
died were malnourished on admission, whereas 62.2% of those who survived were malnourished on 
admission.  No significant relationship between the influence of nutritional status on admission, or 
the degree thereof, on outcome was found, even after accounting for confounding variables (stage 
of disease and histology). 
 
Just over 84% of subjects were provided with nutritional supplementation, in the form of oral 
supplements and/or NG feeds, within two weeks of admission.  The next chapter discusses the 







CHAPTER 5: DISCUSSION 
 
The purpose of this study was to investigate the influence of nutritional status at the time of 
admission on outcome.  Three objectives were developed in order to address the research question.  
Firstly, to determine the prevalence of malnutrition using a combination of anthropometric and 
biochemical markers, defined by the AHOPCA algorithm.  The second objective was to determine 
the association between nutritional status on admission on the outcome, in terms of overall survival 
and death, amongst children with Wilms' Tumour.  The third objective was to determine the level of 
nutritional intervention prescribed to the subjects.  This chapter discusses the results presented in 
the previous chapter. 
 
 
5.1. Sample characteristics 
The mean age of the sample was 46.5 months (IQR = 37.32 months).  This is in keeping with 
previous research amongst South African children with Wilms' Tumour conducted by Holzinger et 
al (2007) and Visser et al (2014), which showed medians of 3.66 and 3.95 years respectively.  Half 
the sample was made up of females and half males.  Almost all the subjects were of Black African 
ethnicity (97.3%) while 2.6% of the sample was made up of White and Coloured subjects.  This is 
in line with the population profile of the province according to the latest census information, which 
shows that almost 90% of the KZN population comprises Black African, while 7.4% are Indian and 
4.2% are White.  Similarly, the overall population of South Africa is made up of Black Africans 
(79.2%), followed by White (8.9%) and Coloured (8.9%) individuals (Stats SA 2011).  Just over 
70% of the sample presented in disease stages three to five.  This is in accordance with previous 
studies (Abuidris et al 2008), including a study conducted at IALCH which showed over 67% of 
children with Wilms' Tumour presented in stages three to five (Holzinger et al 2007).  
 
5.2. Assessment of nutritional status  
5.2.1. Anthropometry 
When classifying overall nutritional status amongst this sample, a combination of MUAC, TSFT 
and albumin was utilised.  In this study, 66.67% of the subjects were found to be malnourished on 







Assessment of nutritional status of children with solid tumours is problematic due to the effect of 
tumour weight on body weight measurements (Rogers 2014).  In this study, the tumour mass 
(obtained post-operatively) was subtracted from admission weight in order to attain a more accurate 
reflection of nutritional status.  The drawback of this, however, is that by the time the patient goes 
for surgery the tumour size is often considerably smaller than at the time of admission due to the 
effects of prior neoadjuvant therapy (Israels et al 2009).  This can consequently lead to 
overestimation of the prevalence of well-nourished subjects when used in isolation.  In this study, 
after having corrected for tumour mass, measurements utilising weight continued to underestimate 
the prevalence of malnutrition.  When comparing the prevalence of malnutrition according to WFA, 
HFA and BMI (12.68%, 12% and 12% respectively) to MUAC and TSFT measurements (55.40% 
and 52.11% respectively), the lack of correlation between these different types of anthropometric 
measurements was striking. 
 
According to the data from the nutritional surveys conducted amongst South African children in 
1999, 2005 and 2012, the prevalence of stunting (low HFA) slowly declined from 21.6% in 1999 to 
15.4% in 2012 (Shisana et al 2013; Labadarios et al 2008; Labadarios et al 2000).  However, 
stunting continues to be a significant problem in South Africa.  In this study, 12% of the sample 
was stunted, which corresponds to the national prevalence.  Stunting is a reflection of chronic 
under-nutrition (Dewey & Begum 2011).  One may therefore not expect the prevalence to be 
significantly higher amongst children with Wilms' Tumour when presenting to hospital compared to 
that of the general population, as they usually present after an acute period of symptoms, which 
would not contribute to long-term nutritional impairment prior to admission.  In this study, the 
prevalence of underweight, as classified by low WFA, was found to be higher than the latest report 
by the SANHANES-1 study in 2012 (12.68% versus 5.8%).  Low WFA can be a reflection of short- 
and/or long-term malnutrition (De Onis & Blossner 1997).  A higher prevalence of short-term 
malnutrition could be expected amongst this study's sample population as a consequence of disease 
related symptoms such as nausea, vomiting and loss of appetite prior to presentation to hospital. 
 
This study found the prevalence of malnutrition to be just over 66%.  Previous studies in developing 
countries have found the prevalence of malnutrition amongst children with cancer to range from 45 
to 77% (Sala et al 2012; Israels et al 2009; Israels et al 2008; Garofolo et al 2005).  Sala et al 
(2012) conducted a large study which included 1787 children with cancer from seven developing 
countries in Central America.  The authors used similar categories to classify nutritional status as 






in 77.2% of the sample (18% moderate and 59.2% severe), while 59% of those with solid tumours 
were malnourished.  It is evident that the prevalence of malnutrition found in the present study 
corresponds to similar studies previously conducted. 
 
The results of this study are in agreement with several other studies which addressed the fact that 
measurements utilising body weight for classification of nutritional status amongst children with 
cancer, without including arm anthropometry measurements, often leads to an underestimation of 
the prevalence of malnutrition (Israels et al 2008; Tazi et al 2008; Garofolo et al 2005).  This is 
particularly pertinent to children with solid tumours (Tazi et al 2008; Garofolo et al 2005) as 
malnutrition amongst children with solid tumours can be masked (Lemos et al 2014; Israels et al 
2008; Tazi et al 2008) by factors such as tumour mass and fluid shifts (Rogers 2014).  Arm 
anthropometry includes MUAC, which provides a measure of body fatness, and TSFT which 
measures muscle mass (Ramsey et al 1992).  Of importance amongst children with solid tumours is 
the fact that arm anthropometry measurements are independent of tumour size (Tah et al 2012; 
Brennan et al 1999). 
 
Because many studies in the past assessed the prevalence of malnutrition amongst children with 
solid tumours using weight and height measurements in isolation (Burke et al 2013; Pedrosa et al 
2000; Wessels et al 1999), it is possible that the prevalence of malnutrition amongst this population 
has been grossly underestimated.  After conducting a comprehensive search of the literature, only 
four published studies assessing the prevalence of malnutrition amongst South African children 
with Wilms' Tumour were found (Visser et al 2014; Holzinger et al 2007; Davidson, Hartley, 
Desai, Daubenton, Rode & Millar 2006; Wessels et al 1999).  Wessels et al (1999) found that 35% 
of their sample was malnourished, while Davidson et al (2006) and Visser et al (2014) found the 
prevalence of malnutrition to be 20.7% and 10.3% respectively.  Holzinger et al (2007), who 
conducted their study at IALCH, found a prevalence of 45%.  This study was performed from 2002 
to 2005 and did not include the same patient population as the present study.  Unfortunately, all of 
these studies were limited by the fact that they used weight and height in isolation and did not 
include arm anthropometry in their classification.  Furthermore, the studies by Wessels et al (1999) 
and Holzinger et al (2007) had relatively small sample sizes (59 and 37 respectively).   
 
To date there is no published research assessing the prevalence of malnutrition amongst South 
African children with Wilms' Tumour utilising arm anthropometry measurements.  The current 






malnutrition amongst this specific population.  The results of this study are in line with the 
aforementioned literature which emphasises the superior accuracy of arm anthropometry 
measurements when classifying nutritional status amongst this population.  It is evident that arm 
anthropometry measurements should be considered as standard criteria with which to classify 
nutritional status of Wilms' Tumour patients in the future. 
 
The AHOPCA algorithm, on which this study‟s criteria for classifying nutritional status was based, 
incorporates arm anthropometry, albumin, weight loss and percentage of ideal body weight 
measurements.  Initially, the algorithm stated that both MUAC and TSFT had to be below a certain 
value in order for a subject to be classified as malnourished.  These criteria have since changed, 
stipulating that all subjects with either MUAC or TSFT below a certain level be classified as 
malnourished.  This was done in order to increase the sensitivity of the algorithm and to encourage 
interventions amongst a larger proportion of subjects (Sala et al 2005).  
 
5.2.2. Biochemistry 
The results from this study showed that, in isolation, albumin considerably underestimated the 
prevalence of malnutrition (30%).  This is in agreement with previous research by Tazi et al (2008), 
which showed that the prevalence of malnutrition according to albumin was 28%.  However, when 
the authors classified nutritional status according to arm anthropometry, the prevalence of 
malnutrition increased to 39% and 50% using MUAC and TSFT respectively.  When including 
albumin in combination with MUAC and TSFT as part of the assessment of overall nutritional 
status in the current study, the prevalence of malnutrition increased by almost 10%.  Due to its low 
specificity, albumin is considered to be a poor indicator of nutritional status when assessed in 
isolation (Fuhrman 2002).  However, previous research by Sala et al (2012) has shown the inclusion 
of albumin as one of a combination of criteria when classifying nutritional status does add 
considerable value to the accuracy and sensitivity of the classification methodology.  The results of 
this study were in agreement with this evidence. 
 
Interestingly, when looking at all indicators combined (TSFT, MUAC and albumin), eight subjects 
were classified as being malnourished based on their albumin levels alone.  A possible explanation 
for this could be that their MUAC and TSFT measurements were not accurate.  Alternatively, these 
subjects could have been suffering from significant inflammation or infection, which could have led 






Hypothesis one, that the utilisation of weight, height and albumin in isolation would underestimate 
the prevalence of malnutrition, is therefore accepted.  Hypothesis two, that the utilisation of arm 
anthropometry and albumin in combination would allow for more accurate classification of 
nutritional status, is also accepted. 
 
5.3. Influence of disease stage and tumour burden on nutritional status 
A common problem in many developing countries is that of late presentation of children with 
cancer to hospitals (Paintsil et al 2015; Yao et al 2012; Wilde et al 2010; Abuidris et al 2008; 
Ekenze et al 2006).  Children in developing countries may display symptoms of cancer for months 
before presenting to hospital (Ekenze et al 2006).  This is often due to lack of education amongst 
the general population (Yao et al 2012).  As a consequence of this, many children present to 
hospital in the latter stages of disease (Ekenze et al 2006).  A study conducted in KZN, a region 
where almost half of all households are situated in rural areas (Stats SA 2011), showed that children 
living in rural areas were more likely to present to hospital with Wilms' Tumour later than children 
from urban areas, and with more advanced disease (Hadley & Jacobs 1990).  Late presentation and 
advanced disease stage on admission can have extensive consequences, as children with larger 
tumours on admission have been shown to be more severely malnourished than those with smaller 
tumours (Israels et al 2009).  This in turn can negatively affect their outcome (Sala et al 2012) and 
can contribute to poorer prognosis (Kaste et al 2008).   
 
A Sudanese study showed that over 78% of the sample of children with Wilms' Tumour presented 
in stages three or four (Abuidris et al 2008), and a previous study conducted at IALCH showed that 
over 67% of children with Wilms' Tumour presented in stages three to five (Holzinger et al 2007).  
It is evident that the results of this study are in agreement with previous literature.  In this study, 
71% of the sample presented in stages three to five and 15% had a tumour mass that accounted for 
over 10% of their total body weight.  Those in stages two to four showed a trend towards an 
increased likelihood of being malnourished; however the influence of disease stage on nutritional 
status was not found to be significant.  
 
5.4. Factors affecting the outcome of children with cancer  
This study attempted to identify as many factors as possible which could have affected outcome, in 
order to determine the prognostic significance of nutritional status on admission.  Stage and 






Wilms' Tumour (Kaste et al 2008).  In this study, stage and histology were shown to have no 
influence on the outcome of this sample after two years.  Furthermore, no significant relationship 
between severity of malnutrition on admission and outcome was found. 
 
As discussed previously, there are a myriad of factors that affect outcome of children with cancer in 
developing countries.  These include advanced stage of disease at presentation, treatment 
abandonment, histology, lack of education amongst some communities, severity of malnutrition on 
admission, extreme distances between home and treatment facility, financial constraints and 
delayed presentation (Paintsil et al 2015; Slone et al 2014; Antillon et al 2013; Sala et al 2012; Yao 
et al 2012; Wilde et al 2010; Abuidris et al 2008; Ekenze et al 2006; Madani et al 2006; Hadley & 
Jacobs 1990).  Some factors, namely lack of education and delayed presentation, are variables 
beyond the scope of this study.   
 
In developing countries, many patients abandon treatment due to financial constraints, as some of 
the treatments and drugs are not subsidised (Abuidris et al 2008; Ekenze et al 2006).  Families who 
have to travel far distances to and from the treatment facility as well as pay for board and lodging 
while children are admitted to hospital also experience severe financial strain (Abuidris et al 2008).  
In the sub-Saharan Africa region, treatment abandonment occurs in as many as 48% of patients 
(Paintsil et al 2015), while children with Wilms' Tumour in Sudan have been shown to have a 
treatment abandonment rate of over 60% (Abuidris et al 2008).   
 
Facilities, many of which address the abovementioned problems experienced at other hospitals in 
developing countries, are put in place at IALCH in order to try to prevent treatment abandonment.  
State-run hospitals in South Africa, such as IALCH, provide free or subsidised services to patients 
depending on their parental income (Department of Health, Western Cape Government 2015).  In 
most cases all treatment, including surgery, chemo- and radio-therapy, imaging, drugs and 
nutritional supplements and feeds are provided to patients for a nominal fee or completely free of 
charge.  Furthermore, the services of other health professionals such as physiotherapists, 
occupational therapists, social workers and psychologists are available when required. 
 
Treatment of children with cancer at IALCH is supported by the Childhood Cancer Foundation 
South Africa (CHOC), which runs an accommodation facility on the hospital grounds.  This facility 
provides accommodation for caregivers whose children are receiving treatment in the oncology 






accommodation close to the hospital for prolonged periods of time while their children undergo 
treatment.  Lastly, hospital transport is provided for most patients who need to travel from outlying 
areas.  These measures all serve to alleviate the financial burden caregivers may face when their 
children are treated for cancer at IALCH, and may have contributed to a very low rate of treatment 
abandonment amongst this sample. 
 
The aforementioned array of factors have the potential to influence the outcome of children with 
cancer when receiving treatment in hospitals in developing countries.  However, in this study it was 
evident that these factors did not have as much of a positive influence as they may have had at other 
hospitals or in other countries, due to the superior facilities and services available to the patients and 
their families at IALCH.  Furthermore, the patients in this sample had the advantage of being 
managed by an MDT, including a dietitian.  Most of these children received early individualised 
dietary intervention within two weeks of admission to hospital.  This included a nutritional 
assessment on admission to determine which type of dietary intervention would be most appropriate 
for each patient.  Individualised dietary interventions have been shown to be effective in achieving 
weight gain amongst children with cancer during the course of treatment (De Waele et al 2015).  
Attainment of normal nutritional status for more than 50% of the treatment period has been shown 
to reduce the risk of poorer outcome that has been associated with malnutrition on admission (Orgel 
et al 2014). 
 
5.5. Influence of poor nutritional status on admission and outcome 
The results of this study showed that just over two thirds of the sample was malnourished on 
admission to hospital.  Nutritional status was not shown to be significantly related to outcome.  The 
correlation between nutritional status on admission and outcome has not been conclusively 
established in previous studies, with some studies showing a significant relationship between these 
two variables while others did not. 
 
Most of the previous research has focused on analysing this relationship amongst children with 
haematological malignancies, with few studies focusing on children with solid tumours.  A large 
study by Hoffmeister et al (2013) analysed 733 American children with haematological 
malignancies who had undergone an haematopoietic stem cell transplant.  They found that those 
with an arm muscle area below the 5th percentile had significantly worse event free survival at 100 
days and three years post-transplant.  Hoffmeister's study was strong as it had a large sample size 






similar to this one includes small sample sizes as well as failure to include arm anthropometry 
(Mejia-Arangure et al 1999; Viana et al 1994).  A study with a large sample of 1025 children with 
haematological malignancies, conducted in the United Kingdom, found no evidence that nutritional 
status on admission was a prognostic indicator of outcome.  While this sample size was substantial, 
Weir et al (1998) did not use arm anthropometry when classifying nutritional status.   
 
Results from previous studies amongst children with solid tumours are similarly inconclusive.  One 
of the largest studies conducted to date, by Sala et al (2012), included children with solid and 
haematological malignancies from seven developing countries in Central America.  The strength of 
this study lay in its large sample size, accurate classification of nutritional status as well as the 
multiple locations from which children were sampled.  The authors found a significant relationship 
between malnutrition and higher mortality rates amongst children with solid tumours, but not 
haematological malignancies (Sala et al 2012).  Similar studies found no significant relationship 
between these variables; however none of these studies took arm anthropometry into account in 
their study design (Burke et al 2013; Pedrosa et al 2000; Wessels et al 1999).  South African 
researchers, Wessels et al (1999) focused specifically on children with Wilms' Tumour in their 
retrospective study.  Limitations related to their classification methods for nutritional status, which 
focused solely on weight and height, were discussed.  In order to compensate for the potential 
overestimation of adequate nutritional status that had been shown to occur when using weight and 
height measurements in isolation, they considered any subject with a weight for height less than 
90% of the expected value to be poorly nourished.  In conclusion, hypothesis three, which proposed 
that subjects who were malnourished on admission would have a worse outcome compared to those 
who were well-nourished on admission, is rejected. 
 
5.6. Level of nutrition support provided 
In this study, nutritional interventions within two weeks of admission to hospital were implemented 
for more than 80% of the study sample.  Nutritional intervention included an initial assessment of 
nutritional status as well as implementation of oral and/or nasogastric supplements.   
 
Children with cancer often struggle to meet their nutritional requirements, due to factors such as 
gastrointestinal complications (Barbosa et al 2012), which is why nutritional intervention amongst 
this population is extremely important.  As discussed previously, nutritional intervention has been 
shown to lead to effective weight gain amongst children with cancer (De Waele et al 2015; Sacks et 






emphasised the importance of utilising clinical judgement in addition to anthropometric assessment 
in order to determine which patients are in need of nutritional intervention.  When treating these 
patients, the challenge faced by the dietitian is to prevent further worsening of nutritional status, as 
well as to attempt to reverse any deterioration in nutritional status that may have already occurred.  
Children with solid tumours in particular are often in need of nutritional interventions.  Compared 
to children with haematological tumours, those with solid tumours have been shown to practice 
food restrictions more often and experience significantly worse eating problems, including nausea, 
vomiting and loss of appetite (Tah et al 2012). 
 
An international study that assessed the nutrition-related practices amongst 125 institutions around 
the world found inconsistent practices related to nutritional interventions (Ladas et al 2006).  A 
similar study conducted amongst South African hospitals also showed a similar lack of uniformity 
(Schoeman 2011).  It is unfortunate that there are no standardised guidelines related to nutritional 
intervention which can be implemented throughout centres that treat children with cancer, as the 
efficacy of nutritional intervention is well documented (De Waele et al 2015; Sacks et al 2014; 
Antillon et al 2013; Barbosa et al 2012).  Nasogastric feeding in particular has been shown to be 
very effective in order to achieve weight gain amongst children with cancer (Brinksma et al 2015; 
Barbosa et al 2012; Holzinger et al 2007).  Furthermore, it has been shown to be effective even 
amongst subjects with cancer cachexia (De Waele et al 2015) as well as the South African Wilms' 
Tumour population (Holzinger et al 2007).  However, the fact that there was no significant 
relationship between severity of malnutrition and type of support received suggests that both oral 
nutritional supplements as well as NG feeds have a role in the nutritional management of severely 
malnourished subjects.   
 
5.7. Multidisciplinary team management 
Multidisciplinary team (MDT) management of children with cancer is especially important in 
developing countries, where a myriad of factors contribute to poorer outcomes amongst this 
population.  Research has shown that a country's socio-economic status is a major determinant of 
the nutritional status of the population (Dowler 2005, p140).  Irrespective of whether a country is 
developed or developing, the literature has demonstrated that weight loss during treatment occurs 
frequently amongst this population (Brinksma et al 2015; Orgel et al 2014; Antillon et al 2013; 
Burke et al 2013; Zimmermann et al 2013).  The MDT approach has been shown to be lacking in 
developing countries.  Effective MDT management helps to improve and promote collaboration 






management (Ekenze et al 2006).  Involvement of a variety of health professionals, including a 
dietitian, in the treatment and follow up of these patients may lead to improved quality of life, and 
has shown to be effective in improving nutritional status amongst patients with cancer cachexia (De 
Waele et al 2015). 
 
The greatest weight changes amongst children with cancer have been shown to occur within three 
months of diagnosis (Brinksma et al 2015), thus emphasising the importance of early and 
aggressive nutritional intervention.  Antillon et al (2013) showed that multidisciplinary 
management, in the form of a combination of nutritional management and intervention as well as 
chemotherapy treatment to control the malignant disease, contributed to improved nutritional status 
after six months of treatment.  The authors showed that, of those who were classified according to 
arm anthropometry as being severely depleted on admission, almost two thirds improved and were 
classified as either moderately malnourished or adequately nourished.  Furthermore, improved 
nutritional status was noted amongst 77% of the moderately malnourished subjects, who were 
classified as adequately nourished after six months.  For the subjects who were severely 
malnourished but for whom an improvement in nutritional status was seen by six months, the 
overall survival probability at five years post admission was similar to those whose nutritional 
status was adequate on admission (Antillon et al 2013).  
 
In a similar study, Orgel et al (2014) found that children with leukaemia who were underweight for 
more than 50% of their treatment period had significantly worse outcomes.  However, those who 
were initially underweight but who gained weight and maintained their normal weight for more than 
50% of the treatment period had similar risk for the occurrence of an event as those who maintained 
a normal weight throughout treatment.  Therefore nutritional monitoring is imperative amongst this 
population, and nutritional intervention needs to be implemented as early as possible.   
 
5.8. Summary 
It is evident that childhood cancer is a serious problem in developing countries.  Just over two thirds 
of this sample was malnourished on admission to hospital.  Nutritional status should be assessed as 
early as possible in order to improve nutritional status or prevent malnutrition from developing.  
Utilisation of a combination of arm anthropometry and albumin provide accurate criteria for 
assessing nutritional status amongst this population.  This helps to minimise the risk of 
underestimation of malnutrition, which commonly occurs when weight and height are used in 






The majority of children with Wilms' Tumour were found to be malnourished on admission to 
IALCH during the period of this study.  The relationship between poor nutritional status on 
admission to hospital and outcome has not been conclusively stipulated in the past.  A myriad of 
factors can affect the outcome of this population, particularly in developing countries where factors 
such as poverty and poor education exacerbate the problems already faced by children with cancer 
and their families.  This study found that malnutrition on admission did not contribute to 
significantly poorer outcomes.  Aggressive early nutritional assessment, intervention and 
management of these children may help to reduce the negative impact that malnutrition on 
admission may have on outcome.  Furthermore, the involvement of a multidisciplinary team in the 
management of children with Wilms' Tumour may help to improve their nutritional status and 







CHAPTER 6: CONCLUSION 
 
Childhood cancer continues to be a serious problem worldwide and in developing countries in 
particular.  The prevalence of malnutrition amongst children with cancer on admission to hospital is 
high amongst developing countries, where poverty is rife and resources are limited.  Wilms' 
Tumour is a commonly occurring solid tumour in African countries.  This study was conducted at 
IALCH and included 76 children diagnosed with Wilms' Tumour between 2004 and 2012. 
 
The following objectives were investigated in this study: 
 To determine the prevalence of malnutrition using a combination of anthropometric and 
biochemical markers, defined by the AHOPCA algorithm. 
 To determine the influence of nutritional status on admission on the outcome, in terms of 
overall survival and death, amongst children with Wilms' Tumour admitted to IALCH 
between 2004 and 2012. 
 To determine the level of nutritional support prescribed to children with Wilms‟ Tumour 
within the first two weeks of admission to IALCH between 2004 and 2012. 
 
This chapter concludes the findings of the study related to the above objectives. Furthermore, it 
discusses the limitations of the study as well as recommendations for future research and for dietetic 
practice. 
 
6.1. Conclusion of the study findings 
6.1.1. Prevalence of malnutrition according to anthropometry 
Utilisation of weight and height measurements in isolation can lead to an underestimation of the 
prevalence of malnutrition amongst children with Wilms‟ Tumour.  This study showed that arm 
anthropometry should be included as part of a standardised method of classifying nutritional status 
amongst children with solid tumours. 
 
6.1.2. Prevalence of malnutrition according to biochemistry  
The findings of this study showed that albumin can add sensitivity to the classification of nutritional 






it should not be considered as a marker of nutritional status in isolation as it leads to an 
overestimation of adequate nutritional status. 
 
6.1.3. Nutritional status and outcome  
This study revealed that no correlation existed between nutritional status on admission and 
outcome.  Many of the previous studies that assessed this relationship were conducted in developing 
countries where resources and facilities are severely limited.  The subjects in this study were treated 
by a multidisciplinary team of health care professionals throughout their treatment period.  
Furthermore, the subjects were treated at a high-level hospital while their caregivers were supported 
by CHOC.  This may have helped to minimise treatment abandonment.  This study showed that 
poor nutritional status on admission did not lead to worsened outcomes amongst this population.  
Holistic and MDT management may play a role in improving the outcome of children with Wilms' 
Tumour who are poorly nourished on admission.     
 
6.1.4. Level of nutritional intervention  
The majority of subjects received nutritional support on admission to hospital.  Nutritional 
assessment on admission is vital in order to determine which patients are malnourished or at risk of 
becoming malnourished.  This allows the dietitian to identify the most appropriate nutritional 
intervention for each subject promptly, before nutritional status worsens. 
 
6.2.  Study limitations 
The sample size was relatively small compared to other international studies.  Due to financial and 
time constraints, this study was limited to only those patients presenting with Wilms' Tumour at 
IALCH between 2004 and 2012.  However, this research is still relevant and important given the 
paucity of research on children with Wilms' Tumour, both internationally and in South Africa.  
Furthermore, based on an extensive literature search, this is the first South African study to use arm 
anthropometry to classify nutritional status amongst this population. 
 
This study may be subject to selection bias due to the fact that it was conducted at a government 
hospital.  However, it is important to note that IALCH serves a catchment area spanning two 
provinces in South Africa and is therefore representative of a wide spectrum of the South African 







Although the Frisancho charts were used in this study to classify nutritional status, this was not 
ideal as these charts are based on a population made up of only Caucasian subjects. 
 
6.3.  Recommendations  
6.3.1. Recommendations for dietetic practice 
It is important to have international standardisation with regards to nutritional assessment on 
admission at all centres treating children with cancer.  This is important in order to identify those in 
need of aggressive nutritional assessment as early as possible, in an attempt to improve their 
nutritional status timeously.  Tumour registries need to be established in all countries in order to 
fully understand the prevalence of paediatric cancer.  Arm anthropometry should be used as an 
integral part of nutritional assessment amongst children with cancer, particularly those with solid 
tumours. 
 
More emphasis needs to be placed on MDT management of these patients.  Cancer has numerous 
and wide-ranging consequences, both physically and emotionally.  It is difficult to improve 
nutritional status alone and holistic management is needed in order for nutritional management to be 
successful. 
 
6.3.2. Recommendations for future research 
In the past, studies such as this have focused on the nutritional status of the subjects on admission in 
relation to outcome (Burke et al 2013; Sala et al 2012; Pedrosa et al 2000; Wessels et al 1999).  
However, recent studies have placed more focus on maintaining adequate nutritional status 
throughout the treatment period as opposed to focusing only on nutritional status on admission 
(Orgel et al 2014; Antillon et al 2013).  This is due to the fact that the literature has demonstrated 
that weight loss during treatment occurs frequently amongst this population (Brinksma et al 2015; 
Orgel et al 2014; Antillon et al 2013; Burke et al 2013; Zimmermann et al 2013).  Zimmerman et al 
(2013) showed a steady increase in the prevalence of malnutrition from 5.8% on admission to 47% 
by the end of the treatment period.  Similarly, Burke et al (2013) found that almost 20% of subjects 
lost more than 5% and 10% of their baseline weight after six months.  It has been postulated that 
nutritional status at six months after treatment has commenced has been shown to be a more 







Future research should focus on nutritional management of children with cancer during the 
treatment period.  This research should focus on the association between the type and duration of 
intervention and their influence on weight and outcome.  This will help to determine the most 
effective methods with regards to timing and type of nutritional intervention in order to prevent the 
progressive weight loss that is commonly seen amongst these subjects during cancer treatment.   
 
In spite of considerable support offered to the subjects of this study, several were still lost due to a 
lack of follow up. An epidemiological-based study to identify factors which continue to contribute 
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